<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Data</journal-id><journal-id journal-id-type="iso-abbrev">Sci Data</journal-id><journal-title-group><journal-title>Scientific Data</journal-title></journal-title-group><issn pub-type="epub">2052-4463</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7550587</article-id><article-id pub-id-type="publisher-id">642</article-id><article-id pub-id-type="doi">10.1038/s41597-020-00642-8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Analysis</subject></subj-group></article-categories><title-group><article-title>Large eQTL meta-analysis reveals differing patterns between cerebral cortical and cerebellar brain regions</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1033-0954</contrib-id><name><surname>Sieberts</surname><given-names>Solveig K.</given-names></name><address><email>solly.sieberts@sagebase.org</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Perumal</surname><given-names>Thanneer M.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3231-9134</contrib-id><name><surname>Carrasquillo</surname><given-names>Minerva M.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Allen</surname><given-names>Mariet</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1783-4453</contrib-id><name><surname>Reddy</surname><given-names>Joseph S.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0957-0224</contrib-id><name><surname>Hoffman</surname><given-names>Gabriel E.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7512-4476</contrib-id><name><surname>Dang</surname><given-names>Kristen K.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Calley</surname><given-names>John</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Ebert</surname><given-names>Philip J.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Eddy</surname><given-names>James</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Xue</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Greenwood</surname><given-names>Anna K.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Mostafavi</surname><given-names>Sara</given-names></name><xref ref-type="aff" rid="Aff6">6</xref><xref ref-type="aff" rid="Aff7">7</xref><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author" id="IAu1"><collab>The CommonMind Consortium (CMC)<contrib-group><contrib contrib-type="author"><name><surname>Akbarian</surname><given-names>Schahram</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Bendl</surname><given-names>Jaroslav</given-names></name><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><name><surname>Breen</surname><given-names>Michael S.</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name><surname>Brennand</surname><given-names>Kristen</given-names></name><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><name><surname>Brown</surname><given-names>Leanne</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Browne</surname><given-names>Andrew</given-names></name><xref ref-type="aff" rid="Aff12">12</xref><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name><surname>Buxbaum</surname><given-names>Joseph D.</given-names></name><xref ref-type="aff" rid="Aff12">12</xref><xref ref-type="aff" rid="Aff13">13</xref><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name><surname>Charney</surname><given-names>Alexander</given-names></name><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><name><surname>Chess</surname><given-names>Andrew</given-names></name><xref ref-type="aff" rid="Aff15">15</xref><xref ref-type="aff" rid="Aff16">16</xref><xref ref-type="aff" rid="Aff17">17</xref></contrib><contrib contrib-type="author"><name><surname>Couto</surname><given-names>Lizette</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Crawford</surname><given-names>Greg</given-names></name><xref ref-type="aff" rid="Aff18">18</xref><xref ref-type="aff" rid="Aff19">19</xref></contrib><contrib contrib-type="author"><name><surname>Devillers</surname><given-names>Olivia</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Devlin</surname><given-names>Bernie</given-names></name><xref ref-type="aff" rid="Aff20">20</xref></contrib><contrib contrib-type="author"><name><surname>Dobbyn</surname><given-names>Amanda</given-names></name><xref ref-type="aff" rid="Aff12">12</xref><xref ref-type="aff" rid="Aff21">21</xref></contrib><contrib contrib-type="author"><name><surname>Domenici</surname><given-names>Enrico</given-names></name><xref ref-type="aff" rid="Aff22">22</xref></contrib><contrib contrib-type="author"><name><surname>Filosi</surname><given-names>Michele</given-names></name><xref ref-type="aff" rid="Aff22">22</xref></contrib><contrib contrib-type="author"><name><surname>Flatow</surname><given-names>Elie</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Francoeur</surname><given-names>Nancy</given-names></name><xref ref-type="aff" rid="Aff21">21</xref></contrib><contrib contrib-type="author"><name><surname>Fullard</surname><given-names>John</given-names></name><xref ref-type="aff" rid="Aff12">12</xref><xref ref-type="aff" rid="Aff21">21</xref></contrib><contrib contrib-type="author"><name><surname>Gil</surname><given-names>Sergio Espeso</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Girdhar</surname><given-names>Kiran</given-names></name><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><name><surname>Guly&#x000e1;s-Kov&#x000e1;cs</surname><given-names>Attila</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name><surname>Gur</surname><given-names>Raquel</given-names></name><xref ref-type="aff" rid="Aff23">23</xref></contrib><contrib contrib-type="author"><name><surname>Hahn</surname><given-names>Chang-Gyu</given-names></name><xref ref-type="aff" rid="Aff24">24</xref></contrib><contrib contrib-type="author"><name><surname>Haroutunian</surname><given-names>Vahram</given-names></name><xref ref-type="aff" rid="Aff12">12</xref><xref ref-type="aff" rid="Aff17">17</xref></contrib><contrib contrib-type="author"><name><surname>Hauberg</surname><given-names>Mads Engel</given-names></name><xref ref-type="aff" rid="Aff12">12</xref><xref ref-type="aff" rid="Aff25">25</xref></contrib><contrib contrib-type="author"><name><surname>Huckins</surname><given-names>Laura</given-names></name><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><name><surname>Jacobov</surname><given-names>Rivky</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Jiang</surname><given-names>Yan</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Johnson</surname><given-names>Jessica S.</given-names></name><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><name><surname>Kassim</surname><given-names>Bibi</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Yungil</given-names></name><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><name><surname>Klei</surname><given-names>Lambertus</given-names></name><xref ref-type="aff" rid="Aff20">20</xref></contrib><contrib contrib-type="author"><name><surname>Kramer</surname><given-names>Robin</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name><surname>Lauria</surname><given-names>Mario</given-names></name><xref ref-type="aff" rid="Aff27">27</xref></contrib><contrib contrib-type="author"><name><surname>Lehner</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="Aff28">28</xref></contrib><contrib contrib-type="author"><name><surname>Lewis</surname><given-names>David A.</given-names></name><xref ref-type="aff" rid="Aff20">20</xref></contrib><contrib contrib-type="author"><name><surname>Lipska</surname><given-names>Barbara K.</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name><surname>Montgomery</surname><given-names>Kelsey</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Park</surname><given-names>Royce</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Rosenbluh</surname><given-names>Chaggai</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name><surname>Roussos</surname><given-names>Panagiotis</given-names></name><xref ref-type="aff" rid="Aff11">11</xref><xref ref-type="aff" rid="Aff14">14</xref><xref ref-type="aff" rid="Aff15">15</xref><xref ref-type="aff" rid="Aff29">29</xref></contrib><contrib contrib-type="author"><name><surname>Ruderfer</surname><given-names>Douglas M.</given-names></name><xref ref-type="aff" rid="Aff30">30</xref></contrib><contrib contrib-type="author"><name><surname>Senthil</surname><given-names>Geetha</given-names></name><xref ref-type="aff" rid="Aff28">28</xref></contrib><contrib contrib-type="author"><name><surname>Shah</surname><given-names>Hardik R.</given-names></name><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name><surname>Sloofman</surname><given-names>Laura</given-names></name><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><name><surname>Song</surname><given-names>Lingyun</given-names></name><xref ref-type="aff" rid="Aff18">18</xref></contrib><contrib contrib-type="author"><name><surname>Stahl</surname><given-names>Eli</given-names></name><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><name><surname>Sullivan</surname><given-names>Patrick</given-names></name><xref ref-type="aff" rid="Aff31">31</xref></contrib><contrib contrib-type="author"><name><surname>Visintainer</surname><given-names>Roberto</given-names></name><xref ref-type="aff" rid="Aff22">22</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Jiebiao</given-names></name><xref ref-type="aff" rid="Aff32">32</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Ying-Chih</given-names></name><xref ref-type="aff" rid="Aff15">15</xref></contrib><contrib contrib-type="author"><name><surname>Wiseman</surname><given-names>Jennifer</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Xia</surname><given-names>Eva</given-names></name><xref ref-type="aff" rid="Aff21">21</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Wen</given-names></name><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><name><surname>Zharovsky</surname><given-names>Elizabeth</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib></contrib-group></collab></contrib><contrib contrib-type="author"><collab>The&#x000a0;AMP-AD Consortium<contrib-group><contrib contrib-type="author"><name><surname>Addis</surname><given-names>Laura</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Addo</surname><given-names>Sadiya N.</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name><surname>Airey</surname><given-names>David Charles</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Arnold</surname><given-names>Matthias</given-names></name><xref ref-type="aff" rid="Aff34">34</xref></contrib><contrib contrib-type="author"><name><surname>Bennett</surname><given-names>David A.</given-names></name><xref ref-type="aff" rid="Aff35">35</xref></contrib><contrib contrib-type="author"><name><surname>Bi</surname><given-names>Yingtao</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name><surname>Biber</surname><given-names>Knut</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name><surname>Blach</surname><given-names>Colette</given-names></name><xref ref-type="aff" rid="Aff36">36</xref></contrib><contrib contrib-type="author"><name><surname>Bradhsaw</surname><given-names>Elizabeth</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Brennan</surname><given-names>Paul</given-names></name><xref ref-type="aff" rid="Aff37">37</xref></contrib><contrib contrib-type="author"><name><surname>Canet-Aviles</surname><given-names>Rosa</given-names></name><xref ref-type="aff" rid="Aff38">38</xref></contrib><contrib contrib-type="author"><name><surname>Cao</surname><given-names>Sherry</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name><surname>Cavalla</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Chae</surname><given-names>Yooree</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>William W.</given-names></name><xref ref-type="aff" rid="Aff39">39</xref></contrib><contrib contrib-type="author"><name><surname>Cheng</surname><given-names>Jie</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name><surname>Collier</surname><given-names>David Andrew</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Dage</surname><given-names>Jeffrey L.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Dammer</surname><given-names>Eric B.</given-names></name><xref ref-type="aff" rid="Aff40">40</xref></contrib><contrib contrib-type="author"><name><surname>Davis</surname><given-names>Justin Wade</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name><surname>Davis</surname><given-names>John</given-names></name><xref ref-type="aff" rid="Aff37">37</xref></contrib><contrib contrib-type="author"><name><surname>Drake</surname><given-names>Derek</given-names></name><xref ref-type="aff" rid="Aff41">41</xref></contrib><contrib contrib-type="author"><name><surname>Duong</surname><given-names>Duc</given-names></name><xref ref-type="aff" rid="Aff40">40</xref></contrib><contrib contrib-type="author"><name><surname>Eastwood</surname><given-names>Brian J.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Ehrlich</surname><given-names>Michelle</given-names></name><xref ref-type="aff" rid="Aff21">21</xref></contrib><contrib contrib-type="author"><name><surname>Ellingson</surname><given-names>Benjamin</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name><surname>Engelmann</surname><given-names>Brett W.</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name><surname>Esmaeelinieh</surname><given-names>Sahar</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name><surname>Felsky</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Funk</surname><given-names>Cory</given-names></name><xref ref-type="aff" rid="Aff42">42</xref></contrib><contrib contrib-type="author"><name><surname>Gaiteri</surname><given-names>Chris</given-names></name><xref ref-type="aff" rid="Aff35">35</xref></contrib><contrib contrib-type="author"><name><surname>Gandy</surname><given-names>Samuel</given-names></name><xref ref-type="aff" rid="Aff43">43</xref></contrib><contrib contrib-type="author"><name><surname>Gao</surname><given-names>Fan</given-names></name><xref ref-type="aff" rid="Aff44">44</xref></contrib><contrib contrib-type="author"><name><surname>Gileadi</surname><given-names>Opher</given-names></name><xref ref-type="aff" rid="Aff37">37</xref></contrib><contrib contrib-type="author"><name><surname>Golde</surname><given-names>Todd</given-names></name><xref ref-type="aff" rid="Aff45">45</xref></contrib><contrib contrib-type="author"><name><surname>Grosskurth</surname><given-names>Shaun E.</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name><surname>Gupta</surname><given-names>Rishi R.</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name><surname>Gutteridge</surname><given-names>Alex X.</given-names></name><xref ref-type="aff" rid="Aff46">46</xref></contrib><contrib contrib-type="author"><name><surname>Haroutunian</surname><given-names>Vahram</given-names></name><xref ref-type="aff" rid="Aff12">12</xref><xref ref-type="aff" rid="Aff17">17</xref></contrib><contrib contrib-type="author"><name><surname>Hooli</surname><given-names>Basavaraj</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Humphryes-Kirilov</surname><given-names>Neil</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Iijima</surname><given-names>Koichi</given-names></name><xref ref-type="aff" rid="Aff47">47</xref></contrib><contrib contrib-type="author"><name><surname>James</surname><given-names>Corey</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Jung</surname><given-names>Paul M.</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name><surname>Kaddurah-Daouk</surname><given-names>Rima</given-names></name><xref ref-type="aff" rid="Aff36">36</xref></contrib><contrib contrib-type="author"><name><surname>Kastenmuller</surname><given-names>Gabi</given-names></name><xref ref-type="aff" rid="Aff34">34</xref></contrib><contrib contrib-type="author"><name><surname>Klein</surname><given-names>Hans-Ulrich</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Kummer</surname><given-names>Markus</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name><surname>Lacor</surname><given-names>Pascale N.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Lah</surname><given-names>James</given-names></name><xref ref-type="aff" rid="Aff40">40</xref></contrib><contrib contrib-type="author"><name><surname>Laing</surname><given-names>Emma</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Levey</surname><given-names>Allan</given-names></name><xref ref-type="aff" rid="Aff40">40</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Yupeng</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Lipsky</surname><given-names>Samantha</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Yushi</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Jimmy</given-names></name><xref ref-type="aff" rid="Aff39">39</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Zhandong</given-names></name><xref ref-type="aff" rid="Aff48">48</xref></contrib><contrib contrib-type="author"><name><surname>Louie</surname><given-names>Gregory</given-names></name><xref ref-type="aff" rid="Aff36">36</xref></contrib><contrib contrib-type="author"><name><surname>Lu</surname><given-names>Tao</given-names></name><xref ref-type="aff" rid="Aff41">41</xref></contrib><contrib contrib-type="author"><name><surname>Ma</surname><given-names>Yiyi</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Matsuoka</surname><given-names>Yasuji Y.</given-names></name><xref ref-type="aff" rid="Aff46">46</xref></contrib><contrib contrib-type="author"><name><surname>Menon</surname><given-names>Vilas</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Miller</surname><given-names>Bradley</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Misko</surname><given-names>Thomas P.</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name><surname>Mollon</surname><given-names>Jennifer E.</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name><surname>Montgomery</surname><given-names>Kelsey</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Mukherjee</surname><given-names>Sumit</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Noggle</surname><given-names>Scott</given-names></name><xref ref-type="aff" rid="Aff49">49</xref></contrib><contrib contrib-type="author"><name><surname>Pao</surname><given-names>Ping-Chieh</given-names></name><xref ref-type="aff" rid="Aff44">44</xref></contrib><contrib contrib-type="author"><name><surname>Pearce</surname><given-names>Tracy Young</given-names></name><xref ref-type="aff" rid="Aff50">50</xref></contrib><contrib contrib-type="author"><name><surname>Pearson</surname><given-names>Neil</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Penny</surname><given-names>Michelle</given-names></name><xref ref-type="aff" rid="Aff39">39</xref></contrib><contrib contrib-type="author"><name><surname>Petyuk</surname><given-names>Vladislav A.</given-names></name><xref ref-type="aff" rid="Aff51">51</xref></contrib><contrib contrib-type="author"><name><surname>Price</surname><given-names>Nathan</given-names></name><xref ref-type="aff" rid="Aff42">42</xref></contrib><contrib contrib-type="author"><name><surname>Quarless</surname><given-names>Danjuma X.</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name><surname>Ravikumar</surname><given-names>Brinda</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name><surname>Ried</surname><given-names>Janina S.</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name><surname>Ruble</surname><given-names>Cara Lee Ann</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Runz</surname><given-names>Heiko</given-names></name><xref ref-type="aff" rid="Aff39">39</xref></contrib><contrib contrib-type="author"><name><surname>Saykin</surname><given-names>Andrew J.</given-names></name><xref ref-type="aff" rid="Aff52">52</xref></contrib><contrib contrib-type="author"><name><surname>Schadt</surname><given-names>Eric</given-names></name><xref ref-type="aff" rid="Aff21">21</xref></contrib><contrib contrib-type="author"><name><surname>Scherschel</surname><given-names>James E.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Seyfried</surname><given-names>Nicholas</given-names></name><xref ref-type="aff" rid="Aff40">40</xref></contrib><contrib contrib-type="author"><name><surname>Shulman</surname><given-names>Joshua M.</given-names></name><xref ref-type="aff" rid="Aff48">48</xref></contrib><contrib contrib-type="author"><name><surname>Snyder</surname><given-names>Phil</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Soares</surname><given-names>Holly</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name><surname>Srivastava</surname><given-names>Gyan P.</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name><surname>Stockmann</surname><given-names>Henning</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name><surname>Taga</surname><given-names>Mariko</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Tasaki</surname><given-names>Shinya</given-names></name><xref ref-type="aff" rid="Aff35">35</xref></contrib><contrib contrib-type="author"><name><surname>Tenenbaum</surname><given-names>Jessie</given-names></name><xref ref-type="aff" rid="Aff36">36</xref></contrib><contrib contrib-type="author"><name><surname>Tsai</surname><given-names>Li-Huei</given-names></name><xref ref-type="aff" rid="Aff44">44</xref></contrib><contrib contrib-type="author"><name><surname>Vasanthakumar</surname><given-names>Aparna</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name><surname>Wachter</surname><given-names>Astrid</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Yaming</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Hong</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Minghui</given-names></name><xref ref-type="aff" rid="Aff21">21</xref></contrib><contrib contrib-type="author"><name><surname>Whelan</surname><given-names>Christopher D.</given-names></name><xref ref-type="aff" rid="Aff39">39</xref></contrib><contrib contrib-type="author"><name><surname>White</surname><given-names>Charles</given-names></name><xref ref-type="aff" rid="Aff53">53</xref></contrib><contrib contrib-type="author"><name><surname>Woo</surname><given-names>Kara H.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Wren</surname><given-names>Paul</given-names></name><xref ref-type="aff" rid="Aff46">46</xref></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Jessica W.</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name><surname>Xi</surname><given-names>Hualin S.</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name><surname>Yankner</surname><given-names>Bruce A.</given-names></name><xref ref-type="aff" rid="Aff41">41</xref></contrib><contrib contrib-type="author"><name><surname>Younkin</surname><given-names>Steven G.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Yu</surname><given-names>Lei</given-names></name><xref ref-type="aff" rid="Aff35">35</xref></contrib><contrib contrib-type="author"><name><surname>Zavodszky</surname><given-names>Maria</given-names></name><xref ref-type="aff" rid="Aff39">39</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Wenling</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Guoqiang</given-names></name><xref ref-type="aff" rid="Aff39">39</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Bin</given-names></name><xref ref-type="aff" rid="Aff21">21</xref></contrib><contrib contrib-type="author"><name><surname>Zhu</surname><given-names>Jun</given-names></name><xref ref-type="aff" rid="Aff21">21</xref></contrib></contrib-group></collab></contrib><contrib contrib-type="author"><name><surname>Omberg</surname><given-names>Larsson</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Peters</surname><given-names>Mette A.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0572-2569</contrib-id><name><surname>Logsdon</surname><given-names>Benjamin A.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8057-2505</contrib-id><name><surname>De Jager</surname><given-names>Philip L.</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Ertekin-Taner</surname><given-names>Nil&#x000fc;fer</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7841-3612</contrib-id><name><surname>Mangravite</surname><given-names>Lara M.</given-names></name><address><email>lara.mangravite@sagebase.org</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.430406.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 6023 5303</institution-id><institution>Sage Bionetworks, </institution></institution-wrap>Seattle, WA 98121 USA </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.417467.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 0443 9942</institution-id><institution>Department of Neuroscience, </institution><institution>Mayo Clinic Florida, </institution></institution-wrap>Jacksonville, FL 32224 USA </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.59734.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0670 2351</institution-id><institution>Pamela Sklar Division of Psychiatric Genomics, Department of Genetics and Genomic Sciences, </institution><institution>Icahn School of Medicine at Mount Sinai, </institution></institution-wrap>New York, NY 10029 USA </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.59734.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0670 2351</institution-id><institution>Icahn Institute for Data Science and Genomic Technology, Department of Genetics and Genomic Sciences, </institution><institution>Icahn School of Medicine at Mount Sinai, </institution></institution-wrap>New York, NY 10029 USA </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.417540.3</institution-id><institution-id institution-id-type="ISNI">0000 0000 2220 2544</institution-id><institution>Lilly Research Labs, </institution><institution>Eli Lilly and Company, </institution></institution-wrap>Indianapolis, IN 46225 USA </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.17091.3e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2288 9830</institution-id><institution>Departments of Statistics and Medical Genetics, </institution><institution>University of British Columbia, </institution></institution-wrap>Vancouver, British Columbia Canada </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.17091.3e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2288 9830</institution-id><institution>Centre for Molecular Medicine and Therapeutics, </institution></institution-wrap>Vancouver, British Columbia Canada </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.440050.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 0408 2525</institution-id><institution>Canadian Institute for Advanced Research, </institution><institution>CIFAR Program in Child and Brain Development, </institution></institution-wrap>Toronto, Ontario Canada </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.239585.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2285 2675</institution-id><institution>Center for Translational &#x00026; Computational Neuroimmunology, Department of Neurology, </institution><institution>Columbia University Medical Center, </institution></institution-wrap>New York, NY 10032 USA </aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="GRID">grid.417467.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 0443 9942</institution-id><institution>Department of Neurology, </institution><institution>Mayo Clinic Florida, </institution></institution-wrap>Jacksonville, FL 32224 USA </aff><aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="GRID">grid.59734.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0670 2351</institution-id><institution>Division of Psychiatric Epigenomics, Department of Psychiatry, </institution><institution>Icahn School of Medicine at Mount Sinai, </institution></institution-wrap>New York, New York USA </aff><aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="GRID">grid.59734.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0670 2351</institution-id><institution>Division of Psychiatric Genomics, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, </institution></institution-wrap>New York, New York USA </aff><aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="GRID">grid.59734.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0670 2351</institution-id><institution>Seaver Autism for Research and Treatment, Department of Psychiatry, </institution><institution>Icahn School of Medicine at Mount Sinai, </institution></institution-wrap>New York, New York USA </aff><aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="GRID">grid.59734.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0670 2351</institution-id><institution>Friedman Brain Institute, </institution><institution>Icahn School of Medicine at Mount Sinai, </institution></institution-wrap>New York, New York USA </aff><aff id="Aff15"><label>15</label><institution-wrap><institution-id institution-id-type="GRID">grid.59734.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0670 2351</institution-id><institution>Institute for Genomics and Multiscale Biology, Department of Genetics and Genomic Sciences, </institution><institution>Icahn School of Medicine at Mount Sinai, </institution></institution-wrap>New York, New York USA </aff><aff id="Aff16"><label>16</label><institution-wrap><institution-id institution-id-type="GRID">grid.59734.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0670 2351</institution-id><institution>Department of Cell, Developmental and Regenerative Biology, </institution><institution>Icahn School of Medicine at Mount Sinai, </institution></institution-wrap>New York, New York USA </aff><aff id="Aff17"><label>17</label><institution-wrap><institution-id institution-id-type="GRID">grid.59734.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0670 2351</institution-id><institution>Department of Neuroscience, </institution><institution>Icahn School of Medicine at Mount Sinai, </institution></institution-wrap>New York, New York USA </aff><aff id="Aff18"><label>18</label><institution-wrap><institution-id institution-id-type="GRID">grid.26009.3d</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7961</institution-id><institution>Center for Genomic &#x00026; Computational Biology, Duke University, </institution></institution-wrap>Durham, North Carolina USA </aff><aff id="Aff19"><label>19</label><institution-wrap><institution-id institution-id-type="GRID">grid.26009.3d</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7961</institution-id><institution>Division of Medical Genetics, Department of Pediatrics, </institution><institution>Duke University, </institution></institution-wrap>Durham, North Carolina USA </aff><aff id="Aff20"><label>20</label><institution-wrap><institution-id institution-id-type="GRID">grid.21925.3d</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9000</institution-id><institution>Department of Psychiatry, </institution><institution>University of Pittsburgh School of Medicine, </institution></institution-wrap>Pittsburgh, Pennsylvania USA </aff><aff id="Aff21"><label>21</label><institution-wrap><institution-id institution-id-type="GRID">grid.59734.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0670 2351</institution-id><institution>Department of Genetics and Genomic Sciences, </institution><institution>Icahn School of Medicine at Mount Sinai, </institution></institution-wrap>New York, New York USA </aff><aff id="Aff22"><label>22</label><institution-wrap><institution-id institution-id-type="GRID">grid.11696.39</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0351</institution-id><institution>Laboratory of Neurogenomic Biomarkers, Centre for Integrative Biology (CIBIO), </institution><institution>University of Trento, </institution></institution-wrap>Trento, Italy </aff><aff id="Aff23"><label>23</label><institution-wrap><institution-id institution-id-type="GRID">grid.25879.31</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8972</institution-id><institution>Neuropsychiatry Section, Department of Psychiatry, Perelman School of Medicine, </institution><institution>University of Pennsylvania, </institution></institution-wrap>Philadelphia, Pennsylvania USA </aff><aff id="Aff24"><label>24</label><institution-wrap><institution-id institution-id-type="GRID">grid.25879.31</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8972</institution-id><institution>Neuropsychiatric Signaling Program, Department of Psychiatry, Perelman School of Medicine, </institution><institution>University of Pennsylvania, </institution></institution-wrap>Philadelphia, Pennsylvania USA </aff><aff id="Aff25"><label>25</label><institution-wrap><institution-id institution-id-type="GRID">grid.7048.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 1956 2722</institution-id><institution>Department of Biomedicine, </institution><institution>Aarhus University, </institution></institution-wrap>Aarhus, Denmark </aff><aff id="Aff26"><label>26</label><institution-wrap><institution-id institution-id-type="GRID">grid.416868.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 0464 0574</institution-id><institution>Human Brain Collection Core, National Institutes of Health, NIMH, </institution></institution-wrap>Bethesda, Maryland USA </aff><aff id="Aff27"><label>27</label><institution-wrap><institution-id institution-id-type="GRID">grid.11696.39</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0351</institution-id><institution>Department of Mathematics, </institution><institution>University of Trento, </institution></institution-wrap>Trento, Italy </aff><aff id="Aff28"><label>28</label><institution-wrap><institution-id institution-id-type="GRID">grid.416868.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 0464 0574</institution-id><institution>National Institute of Mental Health, </institution></institution-wrap>Bethesda, Maryland USA </aff><aff id="Aff29"><label>29</label><institution-wrap><institution-id institution-id-type="GRID">grid.501448.c</institution-id><institution>Psychiatry, JJ Peters VA Medical Center, Bronx, </institution></institution-wrap>New York, USA </aff><aff id="Aff30"><label>30</label><institution-wrap><institution-id institution-id-type="GRID">grid.412807.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9916</institution-id><institution>Department of Medicine, Psychiatry and Biomedical Informatics, Vanderbilt Genetics Institute, </institution><institution>Vanderbilt University Medical Center, </institution></institution-wrap>Nashville, Tennessee USA </aff><aff id="Aff31"><label>31</label><institution-wrap><institution-id institution-id-type="GRID">grid.10698.36</institution-id><institution-id institution-id-type="ISNI">0000000122483208</institution-id><institution>Department of Genetics, </institution><institution>University of North Carolina at Chapel Hill, </institution></institution-wrap>Chapel Hill, North Carolina USA </aff><aff id="Aff32"><label>32</label><institution-wrap><institution-id institution-id-type="GRID">grid.21925.3d</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9000</institution-id><institution>Department of Biostatistics, </institution><institution>University of Pittsburgh, </institution></institution-wrap>Pittsburgh, Pennsylvania USA </aff><aff id="Aff33"><label>33</label><institution-wrap><institution-id institution-id-type="GRID">grid.431072.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 0572 4227</institution-id><institution>AbbVie Inc, </institution></institution-wrap>Chicago, IL USA </aff><aff id="Aff34"><label>34</label><institution-wrap><institution-id institution-id-type="GRID">grid.4567.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 0483 2525</institution-id><institution>Helmholtz Zentrum M&#x000fc;nchen, </institution></institution-wrap>Neuherberg, Germany </aff><aff id="Aff35"><label>35</label><institution-wrap><institution-id institution-id-type="GRID">grid.240684.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0705 3621</institution-id><institution>Rush Alzheimer&#x02019;s Disease Center, </institution><institution>Rush University Medical Center, </institution></institution-wrap>Chicago, IL USA </aff><aff id="Aff36"><label>36</label><institution-wrap><institution-id institution-id-type="GRID">grid.26009.3d</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7961</institution-id><institution>Duke University, </institution></institution-wrap>Durham, NC USA </aff><aff id="Aff37"><label>37</label><institution-wrap><institution-id institution-id-type="GRID">grid.4991.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8948</institution-id><institution>Nuffield Department of Medicine, </institution><institution>Oxford University, </institution></institution-wrap>Headington, UK </aff><aff id="Aff38"><label>38</label><institution-wrap><institution-id institution-id-type="GRID">grid.428807.1</institution-id><institution-id institution-id-type="ISNI">0000 0000 9836 9834</institution-id><institution>Foundation for the National Institutes of Health (FNIH), </institution></institution-wrap>Bethesda, MD USA </aff><aff id="Aff39"><label>39</label><institution-wrap><institution-id institution-id-type="GRID">grid.417832.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 0384 8146</institution-id><institution>Biogen Inc, </institution></institution-wrap>Cambridge, MA USA </aff><aff id="Aff40"><label>40</label><institution-wrap><institution-id institution-id-type="GRID">grid.189967.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 0941 6502</institution-id><institution>Emory University, </institution></institution-wrap>Atlanta, GA USA </aff><aff id="Aff41"><label>41</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Department of Genetics, </institution><institution>Harvard Medical School, </institution></institution-wrap>Boston, MA USA </aff><aff id="Aff42"><label>42</label><institution-wrap><institution-id institution-id-type="GRID">grid.64212.33</institution-id><institution-id institution-id-type="ISNI">0000 0004 0463 2320</institution-id><institution>Institute for Systems Biology, </institution></institution-wrap>Seattle, WA USA </aff><aff id="Aff43"><label>43</label><institution-wrap><institution-id institution-id-type="GRID">grid.59734.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0670 2351</institution-id><institution>Neurology, Icahn School of Medicine at Mount Sinai, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff44"><label>44</label><institution-wrap><institution-id institution-id-type="GRID">grid.116068.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 2341 2786</institution-id><institution>Picower Institute, Massachusetts Institute of Technology, </institution></institution-wrap>Cambridge, MA USA </aff><aff id="Aff45"><label>45</label><institution-wrap><institution-id institution-id-type="GRID">grid.15276.37</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8091</institution-id><institution>Department of Neuroscience, </institution><institution>University of Florida, </institution></institution-wrap>Gainesville, FL USA </aff><aff id="Aff46"><label>46</label><institution-wrap><institution-id institution-id-type="GRID">grid.418236.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 2162 0389</institution-id><institution>GlaxoSmithKline, </institution></institution-wrap>Brentford, UK </aff><aff id="Aff47"><label>47</label><institution-wrap><institution-id institution-id-type="GRID">grid.419257.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 1791 9005</institution-id><institution>National Center for Geriatrics and Gerontology, </institution></institution-wrap>Nagoya, Japan </aff><aff id="Aff48"><label>48</label><institution-wrap><institution-id institution-id-type="GRID">grid.39382.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 2160 926X</institution-id><institution>Baylor College of Medicine, </institution></institution-wrap>Houston, TX USA </aff><aff id="Aff49"><label>49</label><institution-wrap><institution-id institution-id-type="GRID">grid.430819.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 5906 3313</institution-id><institution>New York Stem Cell Foundation, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff50"><label>50</label><institution-wrap><institution-id institution-id-type="GRID">grid.62560.37</institution-id><institution-id institution-id-type="ISNI">0000 0004 0378 8294</institution-id><institution>Brigham &#x00026; Women&#x02019;s Hospital, </institution></institution-wrap>Boston, MA USA </aff><aff id="Aff51"><label>51</label><institution-wrap><institution-id institution-id-type="GRID">grid.451303.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2218 3491</institution-id><institution>Pacific Northwest National Laboratory, </institution></institution-wrap>Richland, WA USA </aff><aff id="Aff52"><label>52</label><institution-wrap><institution-id institution-id-type="GRID">grid.257413.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2287 3919</institution-id><institution>Indiana University School of Medicine, </institution></institution-wrap>Indianapolis, IN USA </aff><aff id="Aff53"><label>53</label><institution-wrap><institution-id institution-id-type="GRID">grid.66859.34</institution-id><institution>Broad Institute, </institution></institution-wrap>Cambridge, MA USA </aff></contrib-group><pub-date pub-type="epub"><day>12</day><month>10</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>12</day><month>10</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>7</volume><elocation-id>340</elocation-id><history><date date-type="received"><day>28</day><month>5</month><year>2019</year></date><date date-type="accepted"><day>24</day><month>8</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2020</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">The availability of high-quality RNA-sequencing and genotyping data of post-mortem brain collections from consortia such as CommonMind Consortium (CMC) and the Accelerating Medicines Partnership for Alzheimer&#x02019;s Disease (AMP-AD) Consortium enable the generation of a large-scale brain <italic>cis-</italic>eQTL meta-analysis. Here we generate cerebral cortical eQTL from 1433 samples available from four cohorts (identifying &#x0003e;4.1 million significant eQTL for &#x0003e;18,000 genes), as well as cerebellar eQTL from 261 samples (identifying 874,836 significant eQTL for &#x0003e;10,000 genes). We find substantially improved power in the meta-analysis over individual cohort analyses, particularly in comparison to the Genotype-Tissue Expression (GTEx) Project eQTL. Additionally, we observed differences in eQTL patterns between cerebral and cerebellar brain regions. We provide these brain eQTL as a resource for use by the research community. As a proof of principle for their utility, we apply a colocalization analysis to identify genes underlying the GWAS association peaks for schizophrenia and identify a potentially novel gene colocalization with lncRNA RP11-677M14.2 (posterior probability of colocalization 0.975).</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Gene regulation</kwd><kwd>Quantitative trait</kwd><kwd>Gene expression</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Defining the landscape of genetic regulation of gene expression in a tissue-specific manner is useful for understanding both normal gene regulation and how variation in gene expression can alter disease risk. In the latter case, a variety of approaches now leverage the association between genetic variants and gene expression changes, including colocalization analysis<sup><xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR7">7</xref></sup>, transcriptome-wide association studies (TWAS)<sup><xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR9">9</xref></sup>, and gene regulatory network inference<sup><xref ref-type="bibr" rid="CR10">10</xref>&#x02013;<xref ref-type="bibr" rid="CR16">16</xref></sup>.</p><p id="Par3">There has been a relative lack of expression quantitative trait loci (eQTL) studies from the brain. Because of the more accessible nature of tissues such as blood or lymphoblastoid cell lines (LCLs), much of the large-scale identification of expression quantitative trait loci (eQTL) has occurred in these tissues<sup><xref ref-type="bibr" rid="CR17">17</xref>&#x02013;<xref ref-type="bibr" rid="CR20">20</xref></sup>. For most other tissues, obtaining samples for RNA sequencing (RNA-seq) requires invasive biopsy, and brain tissues are typically only available in post-mortem brain samples. One effort, the Genotype-Tissue Expression (GTEx) project<sup><xref ref-type="bibr" rid="CR21">21</xref>,<xref ref-type="bibr" rid="CR22">22</xref></sup>, has profiled a broad range of tissues (42 distinct) for eQTL discovery, however, samples sizes in brain have been small (typically 100&#x02013;150). Recently, efforts to understand gene expression changes in neuropsychiatric<sup><xref ref-type="bibr" rid="CR23">23</xref>&#x02013;<xref ref-type="bibr" rid="CR26">26</xref></sup> and neurodegenerative diseases<sup><xref ref-type="bibr" rid="CR27">27</xref>&#x02013;<xref ref-type="bibr" rid="CR34">34</xref></sup> have generated brain RNA-seq from disease and normal tissue, as well as genome-wide genotypes. These analyses have found little evidence for widespread disease-specific eQTL, as well as high cross-cohort overlap<sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR35">35</xref></sup>, meaning that most eQTL detected are disease-condition independent. This implies that meta-analysis across disease-based cohorts will capture eQTL which are unconfounded by disease state despite differences in disease ascertainment of the samples, and leverages thousands of available samples to produce a well-powered brain eQTL resource for use in downstream research.</p><p id="Par4">Here we generate a public eQTL resource from cerebral cortical tissue using 1433 samples from 4 cohorts from the CommonMind Consortium (CMC)<sup><xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR26">26</xref></sup> and the Accelerating Medicines Partnership for Alzheimer&#x02019;s Disease (AMP-AD) Consortium<sup><xref ref-type="bibr" rid="CR30">30</xref>,<xref ref-type="bibr" rid="CR31">31</xref></sup>, as well as from cerebellum using 261 samples from AMP-AD. We show that eQTL discovered in GTEx, which consists of control individuals (without disease) only, are replicated in this larger brain eQTL resource. We further show widespread differences in regulation between cerebral cortex and cerebellum. To demonstrate one example of the utility of these data, we apply a colocalization analysis, which seeks to identify expression traits whose eQTL association pattern appears to co-occur at the same loci as the clinical trait association, to identify putative genes underlying the GWAS association peaks for schizophrenia<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><p id="Par5">We generated eQTL from the publicly available AMP-AD (ROSMAP<sup><xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR35">35</xref>,<xref ref-type="bibr" rid="CR37">37</xref></sup>, Mayo RNAseq<sup><xref ref-type="bibr" rid="CR29">29</xref>,<xref ref-type="bibr" rid="CR38">38</xref>&#x02013;<xref ref-type="bibr" rid="CR40">40</xref></sup>) and CMC<sup><xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR26">26</xref></sup> (MSSM-Penn-Pitt<sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR26">26</xref></sup>, HBCC<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>) cohorts with available genotypes and RNA-seq data, using a common analysis pipeline (Supplementary Table&#x000a0;<xref rid="MOESM5" ref-type="media">1</xref>) (<ext-link ext-link-type="uri" xlink:href="https://www.synapse.org/#!Synapse:syn17015233">https://www.synapse.org/#!Synapse:syn17015233</ext-link>). Analyses proceeded separately by cohort. Briefly, the RNA-seq data were normalized for gene length and GC content prior to adjustment for clinical confounders, processing batch information, and hidden confounders using Surrogate Variable Analysis (SVA)<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>. Genes having at least 1 count per million (CPM) in at least 50% of samples were retained for downstream analysis (Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">2</xref>). Genotypes were imputed to the Haplotype Reference Consortium (HRC) reference panel<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>. eQTL were generated adjusting for diagnosis (AD, control, other for AMP-AD cohorts and schizophrenia, control, other for CMC cohorts) and principal components of ancestry separately for ROSMAP, Mayo temporal cortex (TCX), Mayo cerebellum (CER), MSSM-Penn-Pitt, and HBCC. For HBCC, which had a small number of samples derived from infant and adolescents, we excluded samples with age-of-death less than 18, to limit heterogeneity due to differences between the mature and developing brain.</p><p id="Par6">We then performed a meta-analysis using the eQTL from cortical brain regions from the individual cohorts (dorsolateral prefrontal cortex (DLPFC) from ROSMAP, MSSM-Penn-Pitt, and HBCC and TCX from Mayo). The meta-analysis identifies substantially more eQTL than the individual cohorts (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>, Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). There is a strong relationship between the sample size in the individual cohorts and meta-analysis and the number of significant eQTL and genes with eQTL (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1b,c</xref>). Notably, the meta-analysis identified significant eQTL (at FDR&#x02009;&#x02264;&#x02009;0.05) in &#x0003e;1000 genes for which no eQTL were observed in any individual cohort. Additionally, we find significant eQTL for 18,295 (18,433 when considering markers with minor allele frequency (MAF) down to 1%) of the 19,392 genes included in the analysis.<table-wrap id="Tab1"><label>Table 1</label><caption><p>eQTL results from individual cohorts and meta-analysis.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Cohort</th><th>Cis eQTL*</th><th>Unique Genes with Signif. eQTL</th><th>eQTL (Genes) not Present in GTEx**</th><th>Meta-eQTL (Genes) not found in Cohort</th><th>Genes w/o eQTL in CMC, ROSMAP, HBCC or Mayo TCX</th></tr></thead><tbody><tr><td>ROSMAP</td><td>2,472,838</td><td>13,543</td><td>2,205,025 (7,829)</td><td>2,103,711 (5,079)</td><td/></tr><tr><td>Mayo TCX</td><td>712,401</td><td>8,838</td><td>480,507 (4,439)</td><td>3,485,381 (9,591)</td><td/></tr><tr><td>CMC</td><td>1,322,680</td><td>12,641</td><td>1,062,830 (7,206)</td><td>2,948,886 (5,897)</td><td/></tr><tr><td>HBCC</td><td>577,512</td><td>9,112</td><td>379,732 (4,645)</td><td>3,614,448 (9,337)</td><td/></tr><tr><td><bold>Meta-Analysis***</bold></td><td><bold>4,142,776</bold></td><td><bold>18,295</bold></td><td><bold>3,800,208 (11,395)</bold></td><td/><td><bold>1,042</bold></td></tr></tbody></table><table-wrap-foot><p>*SNP-gene pairs with MAF&#x02009;&#x02265;&#x02009;0.02 and FDR&#x02009;&#x02264;&#x02009;0.05.</p><p>**GTEx (v7) Anterior Cingulate Cortex, Cortex or Frontal Cortex.</p><p>***Additional 36,352 (138) eQTL (Genes) with 0.01&#x02009;&#x02264;&#x02009;MAF&#x02009;&#x0003c;&#x02009;0.02.</p></table-wrap-foot></table-wrap><fig id="Fig1"><label>Fig. 1</label><caption><p>eQTL meta-analysis discovers more eQTL than individual cohorts. (<bold>a</bold>) Quantile-quantile plot of eQTL from individual cohorts as well as the meta-analysis of the true (black) and permuted (light blue) data. Number of significant eQTL (SNP-gene pairs) (<bold>b</bold>) or genes with significant eQTL (<bold>c</bold>) as a function of cohort size.</p></caption><graphic xlink:href="41597_2020_642_Fig1_HTML" id="d30e2557"/></fig></p><p id="Par7">We then compared our cortical eQTL to those from GTEx (v7)<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>, which is the most comprehensive brain eQTL database available in terms of number of available brain tissues (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>, Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Due to the substantially larger power in these data, we find &#x0003e;3.8 million eQTL not identified in GTEx cortical regions (Anterior Cingulate Cortex, Cortex or Frontal Cortex) and we find eQTL for &#x0003e;11,000 genes with no eQTL in these cortical regions in GTEx. While GTEx employs a stricter approach to the control of false discovery rate (FDR), we find that re-analysis of the GTEx cortical regions using an approach similar to ours (see Methods) did not account for the number of eQTL and genes with eQTL discovered in this analysis, but not in GTEx (3,619,693 and 6,866 for eQTL and genes, respectively, when using the less conservative approach). Next, we evaluated the replication within our cortical and cerebellar eQTL of the region specific eQTL identified in GTEx. The cortical eQTL generated through the current analyses strongly replicate the eQTL available through GTEx, not only for cortical regions, but for all brain regions including cervical spinal cord (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Interestingly, the replication in these cortical eQTL of eQTL derived from the two GTEx cerebellar brain regions (cerebellum and cerebellar hemisphere) is consistently lower than for other brain regions represented in GTEx. However, replication of GTEx cerebellar eQTL is high when compared to the cerebellar eQTL generated in this analysis from the Mayo Clinic CER samples. We also performed the reverse comparison, by examining the replication of our eQTL in those region-specific eQTL identified in GTEx. Unsurprisingly, the replication levels were substantially lower, due to the lower power in the GTEx analyses. Replication rates were not substantially changed by using GTEx eQTL discovered using our less conservative approach.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Replication rates between GTEx and publicly available eQTL from these analyses.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">GTEx Brain Region</th><th rowspan="2"># eQTL</th><th colspan="4">Replication (&#x003c0;<sub>1</sub>) of GTEx eQTL</th><th colspan="4">Replication (&#x003c0;<sub>1</sub>) of AMP-AD eQTL in GTEx</th></tr><tr><th>Meta-Analysis</th><th>ROSMAP</th><th>Mayo TCX</th><th>Mayo CER</th><th>Meta-Analysis</th><th>ROSMAP</th><th>Mayo TCX</th><th>Mayo CER</th></tr></thead><tbody><tr><td>Amygdala</td><td>158,270</td><td>0.974</td><td>0.987</td><td>0.986</td><td>0.916</td><td>0.356</td><td>0.421</td><td>0.701</td><td>0.555</td></tr><tr><td>Anterior Cingulate Cortex (BA24)</td><td>291,898</td><td>0.976</td><td>0.971</td><td>0.962</td><td>0.903</td><td>0.445</td><td>0.516</td><td>0.772</td><td>0.592</td></tr><tr><td>Caudate Basal Ganglia</td><td>435,939</td><td>0.966</td><td>0.961</td><td>0.935</td><td>0.881</td><td>0.488</td><td>0.544</td><td>0.781</td><td>0.636</td></tr><tr><td>Cerebellar Hemisphere</td><td>575,583</td><td>0.896</td><td>0.897</td><td>0.781</td><td>0.962</td><td>0.458</td><td>0.509</td><td>0.719</td><td>0.831</td></tr><tr><td>Cerebellum</td><td>819,435</td><td>0.893</td><td>0.890</td><td>0.711</td><td>0.936</td><td>0.526</td><td>0.577</td><td>0.761</td><td>0.863</td></tr><tr><td>Cortex</td><td>478,903</td><td>0.980</td><td>0.973</td><td>0.941</td><td>0.892</td><td>0.547</td><td>0.604</td><td>0.834</td><td>0.659</td></tr><tr><td>Frontal Cortex (BA9)</td><td>342,988</td><td>0.974</td><td>0.967</td><td>0.963</td><td>0.897</td><td>0.489</td><td>0.547</td><td>0.792</td><td>0.632</td></tr><tr><td>Hippocampus</td><td>221,876</td><td>0.967</td><td>0.970</td><td>0.937</td><td>0.905</td><td>0.404</td><td>0.462</td><td>0.710</td><td>0.570</td></tr><tr><td>Hypothalamus</td><td>227,808</td><td>0.974</td><td>0.966</td><td>0.960</td><td>0.913</td><td>0.392</td><td>0.436</td><td>0.719</td><td>0.580</td></tr><tr><td>Nucleus Accumbens Basal Ganglia</td><td>376,390</td><td>0.958</td><td>0.952</td><td>0.781</td><td>0.894</td><td>0.453</td><td>0.514</td><td>0.761</td><td>0.622</td></tr><tr><td>Putamen Basal Ganglia</td><td>293,880</td><td>0.966</td><td>0.974</td><td>0.930</td><td>0.890</td><td>0.433</td><td>0.493</td><td>0.764</td><td>0.591</td></tr><tr><td>Spinal Cord Cervical (c-1)</td><td>175,702</td><td>0.940</td><td>0.952</td><td>0.918</td><td>0.862</td><td>0.330</td><td>0.394</td><td>0.640</td><td>0.514</td></tr><tr><td>Substantia Nigra</td><td>120,582</td><td>0.964</td><td>0.951</td><td>0.960</td><td>0.928</td><td>0.297</td><td>0.372</td><td>0.635</td><td>0.479</td></tr></tbody></table></table-wrap></p><p id="Par8">Additionally, we compared our eQTL to a publically available fetal brain eQTL resource<sup><xref ref-type="bibr" rid="CR43">43</xref></sup> and found good replication of these eQTL as well (estimated replication rate &#x003c0;<sub>1</sub>&#x02009;=&#x02009;0.909 for the cortical meta-analysis, and &#x003c0;<sub>1</sub>&#x02009;=&#x02009;0.861 for cerebellum), though somewhat lower than the replication observed in the GTEx cohorts, which are comprised of adult-derived samples.</p><p id="Par9">Finally, as a proof of concept, we performed a colocalization analysis between our eQTL meta-analysis and the Psychiatric Genomics Consortium (PGC) v2 schizophrenia GWAS summary statistics<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. Seventeen genes showed posterior probability of colocalization using coloc<sup><xref ref-type="bibr" rid="CR7">7</xref></sup> (PP(H<sub>4</sub>))&#x02009;&#x0003e;&#x02009;0.7 (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>), with 3 showing PP(H<sub>4</sub>)&#x02009;&#x0003e;&#x02009;0.95 (FURIN, ZNF823, RP11-677M14.2). FURIN, having previously identified as a candidate through colocalization<sup><xref ref-type="bibr" rid="CR24">24</xref></sup> has recently been shown to reduce brain-derived neurotrophic factor (BDNF) maturation and secretion when inhibited by miR-338-3p<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>. ZNF823 has been identified in previous colocalization analyses<sup><xref ref-type="bibr" rid="CR45">45</xref>,<xref ref-type="bibr" rid="CR46">46</xref></sup>. RP11-677M14.2, a lncRNA located inside NRGN, while not previously identified through colocalization analysis, has been shown to be down-regulated in the amygdala of schizophrenia patients<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>. Noteably, NRGN does not appear to show eQTL colocalization (PP(H<sub>4</sub>)&#x02009;=&#x02009;0.006), instead showing strong evidence for the eQTL and GWAS associations occurring independently (PP(H<sub>3</sub>)&#x02009;=&#x02009;0.994). Two additional strong colocalizations THOC7 (PP(H<sub>4</sub>)&#x02009;=&#x02009;0.943) and FAM85B (PP(H<sub>4</sub>)&#x02009;=&#x02009;0.948) show other potential candidates in the region (Supplementary Table&#x000a0;<xref rid="MOESM3" ref-type="media">3</xref>). At the THOC7 locus, the competing gene, C3orf49 shows slightly lower strength for colocalization (PP(H<sub>4</sub>)&#x02009;=&#x02009;0.820), and the associations do not appear to be independent (R<sup>2</sup> between best SNPs&#x02009;=&#x02009;0.979). At the FAM85B locus, the competing pseudo gene FAM86B3P shows substantially lower evidence for colocalization (PP(H<sub>4</sub>)&#x02009;=&#x02009;0.513) and in this case too, the associations appear to be non-independent (R<sup>2</sup>&#x02009;=&#x02009;0.902).<table-wrap id="Tab3"><label>Table 3</label><caption><p>Top colocalized genes as inferred between meta-analysis eQTL and the PGC2 schizophrenia GWAS.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Gene</th><th colspan="3">eQTL Peak Location*</th><th rowspan="2">N<sub>SNPs</sub></th><th colspan="2">Min(p-value)</th><th rowspan="2">Best Colocalized SNP**</th><th rowspan="2">Posterior Probability of Colocalization</th><th rowspan="2">Additional Candidates at this Locus***</th></tr><tr><th>Chr</th><th>Start</th><th>End</th><th>GWAS</th><th>eQTL</th></tr></thead><tbody><tr><td>RERE</td><td>1</td><td>7412645</td><td>9877280</td><td>4905</td><td>2.72E-09</td><td>2.28E-21</td><td>rs301792</td><td>0.730</td><td/></tr><tr><td>PTPRU</td><td>1</td><td>28563084</td><td>30653243</td><td>4099</td><td>1.28E-09</td><td>4.42E-10</td><td>rs1498232</td><td>0.890</td><td/></tr><tr><td>FOXN2</td><td>2</td><td>47542228</td><td>49606348</td><td>5437</td><td>1.66E-06</td><td>8.85E-45</td><td>rs79073127</td><td>0.782</td><td/></tr><tr><td>C3orf49</td><td>3</td><td>62805378</td><td>64834213</td><td>4906</td><td>2.58E-08</td><td>1.10E-13</td><td>rs832187</td><td>0.820</td><td>Yes</td></tr><tr><td>THOC7</td><td>3</td><td>62819766</td><td>64848612</td><td>4886</td><td>2.58E-08</td><td>2.21E-39</td><td>rs832190</td><td>0.943</td><td>Yes</td></tr><tr><td>TBC1D19</td><td>4</td><td>25578209</td><td>27755954</td><td>4432</td><td>7.44E-07</td><td>7.85E-07</td><td>rs6825268</td><td>0.900</td><td/></tr><tr><td>CLCN3</td><td>4</td><td>169533866</td><td>171644821</td><td>4956</td><td>1.02E-08</td><td>1.91E-09</td><td>rs10520163</td><td>0.768</td><td/></tr><tr><td>PPP1R18</td><td>6</td><td>29644275</td><td>31655438</td><td>1055</td><td>1.16E-19</td><td>5.52E-07</td><td>rs2523607</td><td>0.827</td><td>Yes</td></tr><tr><td>LINC00222</td><td>6</td><td>108073451</td><td>110091064</td><td>3600</td><td>3.37E-08</td><td>1.63E-07</td><td>rs9398171</td><td>0.852</td><td/></tr><tr><td>FAM85B</td><td>8</td><td>8089567</td><td>9084121</td><td>3725</td><td>2.03E-08</td><td>5.63E-31</td><td>rs2980439</td><td>0.948</td><td>Yes</td></tr><tr><td>ENDOG</td><td>9</td><td>130581300</td><td>132584048</td><td>3294</td><td>1.92E-06</td><td>6.90E-62</td><td>rs6478854</td><td>0.721</td><td>Yes</td></tr><tr><td>RP11-677M14.2</td><td>11</td><td>123614560</td><td>125616016</td><td>5253</td><td>3.68E-12</td><td>1.50E-09</td><td>rs55661361</td><td>0.975</td><td/></tr><tr><td>FURIN</td><td>15</td><td>90414642</td><td>92426654</td><td>4767</td><td>2.30E-12</td><td>1.29E-20</td><td>rs4702</td><td>0.999</td><td/></tr><tr><td>CNOT1</td><td>16</td><td>57553885</td><td>59662867</td><td>5364</td><td>1.15E-08</td><td>1.16E-06</td><td>rs12325245</td><td>0.862</td><td/></tr><tr><td>ELAC2</td><td>17</td><td>11896953</td><td>13921426</td><td>5651</td><td>2.84E-06</td><td>3.90E-106</td><td>rs1044564</td><td>0.856</td><td/></tr><tr><td>ZNF823</td><td>19</td><td>10832190</td><td>12840037</td><td>3844</td><td>1.57E-06</td><td>5.38E-10</td><td>rs3095917</td><td>0.961</td><td/></tr><tr><td>PTK6</td><td>20</td><td>61160251</td><td>62960229</td><td>4527</td><td>4.03E-08</td><td>1.09E-26</td><td>rs427230</td><td>0.897</td><td/></tr></tbody></table><table-wrap-foot><p><sup>*</sup>eQTL Peak Location is &#x000b1;1&#x02009;Mb around the gene location.</p><p><sup>**</sup>SNP showing the highest PP(H<sub>4</sub>) between the gene and GWAS trait.</p><p><sup>***</sup>At Posterior Probability of Colocalization &#x02265;&#x000a0;0.5.</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec3" sec-type="discussion"><title>Discussion</title><p id="Par10">Using resources generated in the AMP-AD and CMC consortia, we have generated a well-powered brain eQTL resource for use by the scientific community. Unsurprisingly, we see a strong relationship between the number of significant eQTL, as well as genes with significant eQTL, and sample size using analyses from the individual cohorts as well as the meta-analysis of those cohorts. This result has previously been shown for lower sample sizes<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. We also show higher replication of GTEx eQTL in the meta-analysis relative to the individual cohorts. These conclusions appear to be independent of methodological differences between our analysis and the one done by GTEx.</p><p id="Par11">Notably, we find significant eQTL for nearly every gene in our analysis, which include all but very lowly expressed genes (less than 1&#x02009;cpm in more than 50% of samples). The wide discovery of eQTL is potentially beneficial for analyses utilizing these results, such as colocalization analysis or TWAS imputation, because more genes with significant eQTL means more genes can be evaluated with these approaches. Because we have discovered eQTL for most genes, further increasing sample size will not substantially increase the number of genes with significant eQTL. However it is likely that the number of significant eQTL associations within each gene would continue to increase, which may include additional associations tagging the same regulator or independent associations tagging weaker regulators, along with the accuracy of estimated effect sizes. This will result in a more accurate landscape of regulatory association, which will improve the ability to fine-map causal regions, and colocalize eQTL signal with clinical traits of interest. Thus, it will be valuable to continue to update this meta-analysis with additional data from these consortia and other resources as they become available, and continue to improve this resource as future data permits. Future work may also focus on using well-powered analysis to study the landscape of causal variation and co-variation in gene regulation.</p><p id="Par12">We found distinct eQTL patterns across cerebral cortical and cerebellar brain regions in our resource. Specifically, comparison of eQTL from our resource with those from GTEx shows high replication for the majority of brain regions. However, cerebellar regions show consistently lower replication with the cerebral cortical eQTL generated here. In contrast, the cerebellar eQTL generated from the Mayo Clinic study replicate GTEx cerebellar eQTL at a substantially higher rate, suggesting a different pattern of regulatory variation affecting expression in cerebellum versus other brain regions. Indeed, epigenomic analyses show substantial differences between cerebellar and cerebral cortical regions<sup><xref ref-type="bibr" rid="CR48">48</xref>&#x02013;<xref ref-type="bibr" rid="CR51">51</xref></sup>, particularly in methylation patterns, which could drive different eQTL association patterns. This is further corroborated by the observation of substantial coexpression differences between cerebellar and other brain regions<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>. These effects could be due to differences in cell type composition, with cerebellar regions consisting of substantially more neurons than other brain regions<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>. This is supported by a gene enrichment analysis of genes showing different eQTL association patterns between cerebellum and cortex, which showed that many of the top gene sets were neuron or signaling related (Supplementary Table&#x000a0;<xref rid="MOESM4" ref-type="media">4</xref>). One recent report suggests that there are also widespread differences in histone modifications within cell types derived from cerebellar and cortical regions<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>, though this effect had not been noted in other studies. In particular, Ma <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR54">54</xref></sup> observed that both neuronal and non-neuronal cell types show differing histone modifications across tissue of origin. Further work is necessary to confirm this finding and to develop models to deconvolve the cell-type specific regulatory effects in different brain regions<sup><xref ref-type="bibr" rid="CR55">55</xref>&#x02013;<xref ref-type="bibr" rid="CR57">57</xref></sup>, however our analysis demonstrates that this meta-analysis is representative of eQTL across the majority of brain regions, with the exception of cerebellum. Future meta-analytic analyses may also cast a wider net in terms of brain regions included.</p><p id="Par13">The replication of fetal eQTL, while significant, is somewhat lower than the replication of adult eQTL represented in GTEx. This may be due to multiple factors. The fetal eQTL analysis was generated from brain homogenate, rather than dissected brain regions, though the lower replication likely also reflects broad transcriptional differences between developing and mature brain<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>. These transcriptional differences may also explain why we find substantially more eQTL than a recently published, similarly sized eQTL analysis which uses samples from across developmental and adult timepoints<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>, and why this meta-analysis shows higher replication of GTEx eQTL.</p><p id="Par14">Previous studies report a lack of widespread disease-specific eQTL observed in schizophrenia (CMC)<sup><xref ref-type="bibr" rid="CR24">24</xref></sup> and Alzheimer&#x02019;s (ROSMAP)<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>. In accordance, we find a strong overlap among eQTL across disparate disease samples, particularly those with neuropsychiatric and neurodegenerative disorders, as well as normal individuals from these and other cohorts such as GTEx<sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR35">35</xref></sup>. This suggests that disease-specific eQTL, if they exist, are likely few in number and/or small in effect size, relative to condition-independent eQTL in general. If they do exist, disease-specific eQTL discovery may be successful in more targeted analyses or with larger sample sizes or meta-analyses, but was not explored for the purpose of this general resource. Thus, the heterogeneous samples derived from different disease-based cohorts can be meta-analyzed to create a general-purpose brain eQTL resource representing adult gene regulation, despite comprising samples with different disease backgrounds, along with normal controls. Therefore, these eQTL will be useful both within and outside these specific disease contexts. For example, since these eQTL are not disease specific they may be used to understand healthy gene expression regulation in the brain, as well as to infer colocalization of eQTL signatures with disease risk for any disease whose tissue etiology is from the brain, since these signatures are reflective of normal brain regulation. It should be stated that while many eQTL are not disease specific, i.e. they are identified under various central nervous system (CNS) disease diagnoses and in control brains, they may still contribute to common CNS diseases as previously demonstrated<sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR32">32</xref>&#x02013;<xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR45">45</xref>,<xref ref-type="bibr" rid="CR46">46</xref></sup>. While we have demonstrated a proof-of-concept colocalization analysis with a previously published schizophrenia GWAS, these eQTL are a broadly useful resource for studying neuropsychiatric and neurodegenerative disorders, as well as for understanding the landscape of gene regulation in brain.</p></sec><sec id="Sec4"><title>Methods</title><sec id="Sec5"><title>RNA-seq Re-alignment</title><p id="Par15">For the CMC studies (MSSM-Penn-Pitt, HBCC), RNA-seq reads were aligned to GRCh37 with STAR v2.4.0g1<sup><xref ref-type="bibr" rid="CR59">59</xref></sup> from the original FASTQ files. Uniquely mapping reads overlapping genes were counted with featureCounts v1.5.2<sup><xref ref-type="bibr" rid="CR60">60</xref></sup> using annotations from ENSEMBL v75.</p><p id="Par16">For the AMP-AD studies (ROSMAP, Mayo RNAseq), Picard v2.2.4 (<ext-link ext-link-type="uri" xlink:href="https://broadinstitute.github.io/picard/">https://broadinstitute.github.io/picard/</ext-link>) was used to generate FASTQ files from the available BAM files, using the Picard SamToFastq function. Picard SortSam was first applied to ensure that R1 and R2 reads were correctly ordered in the intermediate SAM file before converting to FASTQ. The converted FASTQs were aligned to the GENCODE24 (GRCh38) reference genome using STAR v2.5.1b, with twopassMode set as Basic. Gene counts were computed for each sample by STAR by setting quantMode as GeneCounts.</p></sec><sec id="Sec6"><title>RNA-seq normalization</title><p id="Par17">To account for differences between samples, studies, experimental batch effects and unwanted RNA-seq-specific technical variations, we performed library normalization and covariate adjustments for each study separately using fixed/mixed effects modeling. A mixed effect model was required to jointly normalize both tissues from the Mayo cohort. All other cohorts contained only one tissue, so a fixed effect model was used. The workflow consisted of the following steps:<list list-type="order"><list-item><p id="Par18"><bold><italic>Gene filtering:</italic></bold> Out of ~56&#x02009;K aligned and quantified genes, only genes showing at least modest expression were used in this analysis. Genes that were expressed more than 1 CPM (read Counts Per Million total reads) in at least 50% of samples in each tissue and diagnosis category were retained for analysis. Additionally, genes with available gene length and percentage GC content from BioMart December 2016 archive were subselected from the above list. This resulted in approximately 14&#x02009;K to 16&#x02009;K genes in each study.</p></list-item><list-item><p id="Par19"><bold><italic>Calculation of normalized expression values:</italic></bold> Sequencing reads were then normalized in two steps. First, conditional quantile normalization (CQN)<sup><xref ref-type="bibr" rid="CR61">61</xref></sup> was applied to account for variations in gene length and GC content. In the second step, the confidence of sampling abundance was estimated using a weighted linear model using the voom-limma package in bioconductor<sup><xref ref-type="bibr" rid="CR62">62</xref>,<xref ref-type="bibr" rid="CR63">63</xref></sup>. The normalized observed read counts, along with the corresponding weights, were used in the following steps.</p></list-item><list-item><p id="Par20"><bold><italic>Outlier detection:</italic></bold> Based on normalized log2(CPM) of expression values, outlier samples were detected using principal component analysis (PCA)<sup><xref ref-type="bibr" rid="CR64">64</xref>,<xref ref-type="bibr" rid="CR65">65</xref></sup> and hierarchical clustering. Samples identified as outliers using both the above methods were removed from further analysis.</p></list-item><list-item><p id="Par21"><bold><italic>Covariate imputation:</italic></bold> Before identifying associated covariates, important missing covariates were imputed. Principally, post-mortem interval (PMI), or the latency between death and tissue collection, which is frequently an important covariate for the analysis of gene expression from post-mortem brain tissue, was imputed for a portion of samples in Mayo RNAseq data for which true values were unavailable. Genomic predictors of PMI were estimated using ROSMAP and MSSM (an additional RNA-seq study available through AMP-AD) samples and were used to impute missing values as necessary.</p></list-item><list-item><p id="Par22"><bold><italic>Covariate identification:</italic></bold> Normalized log2(CPM) counts were then explored to determine which known covariates (both biological and technical) should be adjusted. Except for the HBCC study, we used a stepwise (weighted) fixed/mixed effect regression modeling approach to select the relevant covariates having a significant association with gene expression. Here, covariates were sequentially added to the model if they were significantly associated with any of the top principal components, explaining more than 1% of variance of expression residuals. For HBCC, we used a model selection based on Bayesian information criteria (BIC) to identify the covariates that improve the model in more than 50% of genes.</p></list-item><list-item><p id="Par23"><bold><italic>SVA adjustments:</italic></bold> After identifying the relevant known confounders, hidden-confounders were identified using the Surrogate Variable Analysis (SVA)<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>. We used a similar approach as previously defined<sup><xref ref-type="bibr" rid="CR24">24</xref></sup> to find the number of surrogate variables (SVs), which is more conservative than the default method provided by the SVA package in R<sup><xref ref-type="bibr" rid="CR66">66</xref></sup>. The basic idea of this approach is that for an eigenvector decomposition of permuted residuals each eigenvalue should explain an equal amount of the variation. By the nature of eigenvalues, however, there will always be at least one that exceeds the expected value. Thus, from a series of 100 permutations of residuals (white noise) we identified the number of covariates as shown in Supplementary Table&#x000a0;<xref rid="MOESM5" ref-type="media">1</xref>. We applied the &#x0201c;irw&#x0201d; (iterative re-weighting) version of SVA to the normalized gene expression matrix, along with the covariate model described above to obtain residual gene expression for eQTL analysis.</p></list-item><list-item><p id="Par24"><bold><italic>Covariate adjustments:</italic></bold> We performed a variant of fixed/mixed effect linear regression, choosing mixed-effect models when multiple tissues or samples, were available per individual, as shown here: gene expression ~ Diagnosis&#x02009;+&#x02009;Sex&#x02009;+&#x02009;covariates&#x02009;+&#x02009;(1|Donor), where each gene was linearly regressed independently. Here Donor (individual) was modeled as a random effect when multiple tissues from the same individual were present. Observation weights (if any) were calculated using the voom-limma<sup><xref ref-type="bibr" rid="CR62">62</xref>,<xref ref-type="bibr" rid="CR63">63</xref></sup> pipeline, which has a net effect of up-weighting observations with inferred higher precision in the linear model fitting process to adjust for the mean-variance relationship in RNA-seq data. The diagnosis component was then added back to the residuals to generate covariate-adjusted expression for eQTL analysis.</p></list-item></list></p><p id="Par25">This workflow was applied separately for each study. For the AMP-AD studies, gene locations were lifted over to GRCh37 for comparison with the genotype imputation panel (described below). For HBCC, samples with age &#x0003c;18 were excluded prior to analysis. Supplementary Table&#x000a0;<xref rid="MOESM5" ref-type="media">1</xref> shows the covariates and surrogate variables identified in each study.</p></sec><sec id="Sec7"><title>AD diagnosis harmonization</title><p id="Par26">Prior to RNA-seq normalization, we harmonized the LOAD definition across AMP-AD studies. AD controls were defined as patients with a low burden of plaques and tangles, as well as lack of evidence of cognitive impairment. For the ROSMAP study, we defined AD cases to be individuals with a Braak<sup><xref ref-type="bibr" rid="CR67">67</xref></sup> greater than or equal to 4, CERAD score<sup><xref ref-type="bibr" rid="CR68">68</xref></sup> less than or equal to 2, and a cognitive diagnosis of probable AD with no other causes (cogdx&#x02009;=&#x02009;4), and controls to be individuals with Braak less than or equal to 3, CERAD score greater than or equal to 3, and cognitive diagnosis of &#x02018;no cognitive impairment&#x02019; (cogdx&#x02009;=&#x02009;1). For the Mayo Clinic study, we defined disease status based on neuropathology, where individuals with Braak score greater than or equal to 4 were defined to be AD cases, and individuals with Braak less than or equal to 3 were defined to be controls. Individuals not meeting &#x0201c;AD case&#x0201d; or &#x0201c;control&#x0201d; criteria were retained for analysis, and were categorized as &#x0201c;other&#x0201d; for the purposes of RNA-seq adjustment.</p></sec><sec id="Sec8"><title>Genotype QC and imputation</title><p id="Par27">Genotype QC was performed using PLINK v1.9<sup><xref ref-type="bibr" rid="CR69">69</xref></sup>. Markers with zero alternate alleles, genotyping call rate&#x02009;&#x02264;&#x02009;0.98, Hardy-Weinberg <italic>p</italic>-value&#x02009;&#x0003c;&#x02009;5e&#x02212;5 were removed, as well as individuals with genotyping call rate &#x0003c;&#x000a0;0.90. Samples were then imputed to HRC (Version r1.1 2016)<sup><xref ref-type="bibr" rid="CR42">42</xref></sup> as follows: marker positions were lifted-over to GRCh37, if necessary. Markers were then aligned to the HRC loci using HRC-1000G-check-bim-v4.2 (<ext-link ext-link-type="uri" xlink:href="http://www.well.ox.ac.uk/~wrayner/tools/">http://www.well.ox.ac.uk/~wrayner/tools/</ext-link>), which checks the strand, alleles, position, reference/alternate allele assignments and frequencies of the markers, removing A/T &#x00026; G/C single nucleotide polymorphisms (SNPs) with minor allele frequency (MAF)&#x02009;&#x0003e;&#x02009;0.4, SNPs with differing alleles, SNPs with &#x0003e;&#x000a0;0.2 allele frequency difference between the genotyped samples and the HRC samples, and SNPs not in the reference panel. Imputation was performed via the Michigan Imputation Server<sup><xref ref-type="bibr" rid="CR70">70</xref></sup> using the Eagle v2.3<sup><xref ref-type="bibr" rid="CR71">71</xref></sup> phasing algorithm. Imputation was done separately by cohort and by chip within cohort, and markers with R<sup>2</sup>&#x02009;&#x02265;&#x02009;0.7 and minor allele frequency (MAF)&#x02009;&#x02265;&#x02009;0.01 (within cohort) were retained for analysis.</p></sec><sec id="Sec9"><title>Genetic ancestry inference</title><p id="Par28">GEMTOOLs<sup><xref ref-type="bibr" rid="CR72">72</xref></sup> was used to infer ancestry and compute ancestry components separately by cohort. The GEMTOOLs algorithm uses a significance test to estimate the number of eigenvectors (ancestry components) necessary to represent the variability in the data<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>. For each cohort, we used the top components as estimated by the GEMTOOLs algorithm, which resulted in some variation in the number of components selected. For MSSM-Penn-Pitt and HBCC, which are multi-ethnic cohorts, only Caucasian samples were retained for eQTL analysis.</p></sec><sec id="Sec10"><title>eQTL analysis</title><p id="Par29">eQTL were generated separately in each cohort and tissue using MatrixEQTL<sup><xref ref-type="bibr" rid="CR74">74</xref></sup> adjusting for harmonized Diagnosis and inferred Ancestry components using &#x0201c;cis&#x0201d; gene-marker comparisons: Expression ~ Genotype&#x02009;+&#x02009;Diagnosis&#x02009;+&#x02009;PC<sub>1</sub>&#x02009;+&#x02009;&#x02026;&#x02009;+&#x02009;PC<sub>n,</sub>, where PC<sub>k</sub> is the k<sup>th</sup> ancestry component, using Expression variables which were previously covariate adjusted as described above. Here we define &#x0201c;cis&#x0201d; as &#x000b1; 1 MB around the gene, and GRCh37 gene locations were used for consistency with the marker imputation panel. Meta-analysis was performed via fixed-effect model<sup><xref ref-type="bibr" rid="CR75">75</xref></sup> using an adaptation of the metareg function in the gap package in R. In order to assess potential inflation of Type 1 error, we performed 5 permutations of the gene expression values, relative to genotype and ancestry components, within diagnosis for each cohort, and repeated the regression analyses as described above. For each of the 5 iterations of permutation, a meta-analysis was then performed across the 4 cohorts. We found that Type 1 error was well controlled (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1a</xref>). Given that multiple tissues were present, we also evaluated a random-effect model, but found substantially deflated p-values (less significant) in the permutations, relative to the expected distribution, suggesting that this model is over-conservative.</p></sec><sec id="Sec11"><title>Comparison with GTEx and fetal eQTL</title><p id="Par30">Full summary statistics for the GTEx v7<sup><xref ref-type="bibr" rid="CR21">21</xref></sup> eQTL for all available brain regions were obtained from the GTEx Portal (<ext-link ext-link-type="uri" xlink:href="https://gtexportal.org/">https://gtexportal.org/</ext-link>), and fetal eQTL were obtained from Figshare<sup><xref ref-type="bibr" rid="CR76">76</xref></sup>. For each replication comparison (e.g. meta-analysis vs GTEx or meta-analysis vs. fetal eQTL), only markers and genes present in both the external eQTL and our analysis were retained for comparison. As this was done separately for GTEx and for the fetal eQTL resource, the list of genes and SNPs varies slightly for each comparison. The replication rate was estimated as the &#x003c0;<sub>1</sub> statistic using the qvalue package<sup><xref ref-type="bibr" rid="CR77">77</xref></sup> in R as follows: we extracted the meta-analysis p-values for all SNP-gene pairs, which were significant in GTEx at FDR &#x02264; 0.05. We then applied the &#x02018;qvalue&#x02019; command to the meta-analysis p-values to generate <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\widehat{\pi }}_{1}=1-{\widehat{\pi }}_{0}$$\end{document}</tex-math><mml:math id="M2"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mo>&#x0005e;</mml:mo></mml:mrow></mml:mover></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mo>&#x0005e;</mml:mo></mml:mrow></mml:mover></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41597_2020_642_Article_IEq1.gif"/></alternatives></inline-formula>, which corresponds to estimated proportion of non-null p-values<sup><xref ref-type="bibr" rid="CR77">77</xref></sup>. The &#x02018;smoother&#x02019; option was used to estimate <inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\widehat{\pi }}_{0}$$\end{document}</tex-math><mml:math id="M4"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow><mml:mrow><mml:mo>&#x0005e;</mml:mo></mml:mrow></mml:mover></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41597_2020_642_Article_IEq2.gif"/></alternatives></inline-formula> as a function of the tuning parameter <italic>&#x003bb;</italic> as it approaches 1. The variance around this estimate is relatively small (see Supplementary Figures&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref> and <xref rid="MOESM1" ref-type="media">2</xref> for example) and does not materially affect the observations in this manuscript.</p><p id="Par31">Conversely, we estimated the replication rate of significant meta-analysis eQTL SNP-gene pairs in GTEx. Analogous methods were used to estimate all other replication rates. For the purposes of reporting the total number of eQTL not present in GTEx, and genes without eQTL in GTEx (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>), we have included genes and SNP-gene pairs not present in GTEx in the count, however this accounts for a relatively small proportion of the difference (472,995 eQTL and 1481 genes).</p></sec><sec id="Sec12"><title>GTEx eQTL generation</title><p id="Par32">In order to verify that the observed power increase and replication imbalances were not due to methodological differences between this manuscript and those performed by GTEx, we obtained access to the GTEx v7 data, and generated eQTL for cortex, anterior cingulate cortex, and frontal cortex using our approach. We used gene expression and imputed genotypes as provided, as well as the provided covariates, which included 3 ancestry covariates, 14-15 surrogate variable covariates, sex and platform. We then repeated the comparisons with the meta-analysis described in the previous section, using a MAF cutoff of 0.03, which best appeared to control Type 1 error, as observed by permutation between genotype and gene expression, while maximizing the number of significant eQTL in the true data. Results did not change materially.</p></sec><sec id="Sec13"><title>Pathway analysis of cerebellar eQTL genes</title><p id="Par33">In order to identify whether genes showing cerebellar-specific eQTL patterns showed any biological coherence, we performed a pathway analysis as follows. For genes with at least 5 significant cerebellar eQTL, we computed the Spearman correlation of effect-size between cerebellum eQTL and cortical eQTL for the loci that were significant in cerebellum. We then selected genes for which the effect-sizes did not show positive correlation (Spearman&#x02019;s &#x003c1;&#x02009;&#x0003c;&#x02009;0.1) between the two tissues as showing different eQTL association patterns across the gene and performed a pathway analysis with GO biological processes Fisher&#x02019;s exact test. Note that due to the (power-mediated) greater detection of eQTL in cortex, we did not perform the reverse comparison. The results were relatively robust to the choice of minimum number of significant eQTL, correlation cutoff, and choice of correlation statistic (Spearman vs Pearson).</p></sec><sec id="Sec14"><title>Coloc analysis</title><p id="Par34">We applied Approximate Bayes Factor colocalization (coloc.abf)<sup><xref ref-type="bibr" rid="CR7">7</xref></sup> from the coloc R package to the summary statistics from the PGC2 Schizophrenia GWAS<sup><xref ref-type="bibr" rid="CR36">36</xref></sup> downloaded from the PGC website (<ext-link ext-link-type="uri" xlink:href="http://pgc.unc.edu">http://pgc.unc.edu</ext-link>), and the summary statistics from the eQTL meta-analysis. Each gene present in the meta-analysis was compared to the GWAS in turn, and suggestive and significant GWAS peaks with <italic>p</italic>-value&#x02009;&#x0003c;&#x02009;5e-6 were considered for analysis.</p></sec></sec><sec sec-type="supplementary-material"><title>Supplementary information</title><sec id="Sec15"><supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41597_2020_642_MOESM1_ESM.pdf"><caption><p>Supplementary Figures</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="41597_2020_642_MOESM2_ESM.docx"><caption><p>Supplementary Table 1</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="41597_2020_642_MOESM3_ESM.docx"><caption><p>Supplementary Table 2</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="41597_2020_642_MOESM4_ESM.xlsx"><caption><p>Supplementary Table 3</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM5"><media xlink:href="41597_2020_642_MOESM5_ESM.xlsx"><caption><p>Supplementary Table 4</p></caption></media></supplementary-material></sec></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>A list of authors and their affiliations appears at the end of the paper.</p></fn></fn-group><sec><title>Supplementary information</title><p>is available for this paper at 10.1038/s41597-020-00642-8.</p></sec><ack><title>Acknowledgements</title><p>For the ROSMAP and Mayo RNAseq studies, the results published here are in whole or in part based on data obtained from the AMP-AD Knowledge Portal (doi:10.7303/syn2580853). ROSMAP study data were provided by the Rush Alzheimer&#x02019;s Disease Center, Rush University Medical Center, Chicago. Data collection was supported through funding by NIA grants P30AG10161, R01AG15819, R01AG17917, R01AG30146, R01AG36836, U01AG32984, U01AG46152, the Illinois Department of Public Health, and the Translational Genomics Research Institute. Mayo RNA-seq study data were provided by the following sources: The Mayo Clinic Alzheimers Disease Genetic Studies, led by Dr. Nilufer Ertekin-Taner and Dr. Steven G. Younkin, Mayo Clinic, Jacksonville, FL using samples from the Mayo Clinic Study of Aging, the Mayo Clinic Alzheimer&#x02019;s Disease Research Center, and the Mayo Clinic Brain Bank. Data collection was supported through funding by NIA grants P50 AG016574, R01 AG032990, U01 AG046139, R01 AG018023, U01 AG006576, U01 AG006786, R01 AG025711, R01 AG017216, R01 AG003949, NINDS grant R01 NS080820, CurePSP Foundation, and support from Mayo Foundation. Study data includes samples collected through the Sun Health Research Institute Brain and Body Donation Program of Sun City, Arizona. The Brain and Body Donation Program is supported by the National Institute of Neurological Disorders and Stroke (U24 NS072026 National Brain and Tissue Resource for Parkinsons Disease and Related Disorders), the National Institute on Aging (P30 AG19610 Arizona Alzheimers Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimers Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011, 05-901 and 1001 to the Arizona Parkinson&#x02019;s Disease Consortium) and the Michael J. Fox Foundation for Parkinsons Research. This study was in part supported by NIH RF1 AG051504 and R01 AG061796 (NET). For CommonMind, data were generated as part of the CommonMind Consortium supported by funding from Takeda Pharmaceuticals Company Limited, F. Hoffmann-La Roche Ltd and NIH grants R01MH085542, R01MH093725, P50MH066392, P50MH080405, R01MH097276, RO1-MH-075916, P50M096891, P50MH084053S1, R37MH057881, AG02219, AG05138, MH06692, R01MH110921, R01MH109677, R01MH109897, U01MH103392, and contract HHSN271201300031C through IRP NIMH. Brain tissue for the study was obtained from the following brain bank collections: the Mount Sinai NIH Brain and Tissue Repository, the University of Pennsylvania Alzheimer&#x02019;s Disease Core Center, the University of Pittsburgh NeuroBioBank and Brain and Tissue Repositories, and the NIMH Human Brain Collection Core. CMC Leadership: Panos Roussos, Joseph Buxbaum, Andrew Chess, Schahram Akbarian, Vahram Haroutunian (Icahn School of Medicine at Mount Sinai), Bernie Devlin, David Lewis (University of Pittsburgh), Raquel Gur, Chang-Gyu Hahn (University of Pennsylvania), Enrico Domenici (University of Trento), Mette A. Peters, Solveig Sieberts (Sage Bionetworks), Thomas Lehner, Geetha Senthil, Stefano Marenco, Barbara K. Lipska (NIMH). SKS, TP, KKD, JE, AKG, LO, BAL, and LMM were additionally supported by NIA grants U24 AG61340, U01 AG46170, U01 AG 46161, R01 AG46171, R01 AG 46174. All data used in this manuscript have been previously released through their respective consortia and have been reviewed by IRBs at their institution of origin. Informed consent has been obtained from all individuals.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>S.K.S., S.M., M.P., P.L.D.J., N.E.T. and L.M.M., the AMP-AD Consortium, and the CMC Consortium contributed to the design and generation of the study data. S.K.S., T.P., M.C., M.A., J.S.R., G.H., K.D.D., J.C., P.J.E. and J.E. contributed the data analysis. S.K.S., T.P., G.H., A.K.G., L.O., M.P., B.A.L., L.M.M. contributed to the manuscript preparation and data sharing.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>Data for the ROSMAP<sup><xref ref-type="bibr" rid="CR37">37</xref></sup> and Mayo cohorts<sup><xref ref-type="bibr" rid="CR40">40</xref></sup> are available through the AMP-AD Knowledge Portal<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>. Data for the MSSM-Penn-Pitt and HBCC cohorts are available through the CommonMind Knowledge Portal<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>.</p><p>eQTL results for the ROSMAP<sup><xref ref-type="bibr" rid="CR78">78</xref></sup>, Mayo TCX<sup><xref ref-type="bibr" rid="CR79">79</xref></sup>, Mayo CER<sup><xref ref-type="bibr" rid="CR80">80</xref></sup> and cortical meta-analysis<sup><xref ref-type="bibr" rid="CR81">81</xref></sup> are available through the AMP-AD Knowledge Portal. These results include SNP (location, rsid, alleles, and allele frequency) and gene (location, gene symbol, strand and biotype) information, as well as estimated effect size (beta), statistic (z), p-value, FDR, and expression-increasing allele.</p></notes><notes notes-type="data-availability"><title>Code availability</title><p>An R package with all code for the gene expression normalization is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/Sage-Bionetworks/ampad-diffexp">https://github.com/Sage-Bionetworks/ampad-diffexp</ext-link>. All other analyses were generated using packages publicly available from their respective authors.</p></notes><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par35">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets</article-title><source>Nat. Genet.</source><year>2016</year><volume>48</volume><fpage>481</fpage><lpage>487</lpage><pub-id pub-id-type="doi">10.1038/ng.3538</pub-id><?supplied-pmid 27019110?><pub-id pub-id-type="pmid">27019110</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nica</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Candidate Causal Regulatory Effects by Integration of Expression QTLs with Complex Trait Genetic Associations</article-title><source>PLoS Genet</source><year>2010</year><volume>6</volume><fpage>e1000895</fpage><pub-id pub-id-type="doi">10.1371/journal.pgen.1000895</pub-id><?supplied-pmid 20369022?><pub-id pub-id-type="pmid">20369022</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ongen</surname><given-names>H</given-names></name><etal/></person-group><article-title>Estimating the causal tissues for complex traits and diseases</article-title><source>Nat. Genet.</source><year>2017</year><volume>49</volume><fpage>1676</fpage><lpage>1683</lpage><pub-id pub-id-type="doi">10.1038/ng.3981</pub-id><?supplied-pmid 29058715?><pub-id pub-id-type="pmid">29058715</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chun</surname><given-names>S</given-names></name><etal/></person-group><article-title>Limited statistical evidence for shared genetic effects of eQTLs and autoimmune-disease-associated loci in three major immune-cell types</article-title><source>Nat. Genet.</source><year>2017</year><volume>49</volume><fpage>600</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1038/ng.3795</pub-id><?supplied-pmid 28218759?><pub-id pub-id-type="pmid">28218759</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hormozdiari</surname><given-names>F</given-names></name><name><surname>Kostem</surname><given-names>E</given-names></name><name><surname>Kang</surname><given-names>EY</given-names></name><name><surname>Pasaniuc</surname><given-names>B</given-names></name><name><surname>Eskin</surname><given-names>E</given-names></name></person-group><article-title>Identifying Causal Variants at Loci with Multiple Signals of Association</article-title><source>Genetics</source><year>2014</year><volume>198</volume><fpage>497</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1534/genetics.114.167908</pub-id><?supplied-pmid 25104515?><pub-id pub-id-type="pmid">25104515</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>X</given-names></name><etal/></person-group><article-title>Sherlock: Detecting Gene-Disease Associations by Matching Patterns of Expression QTL and GWAS. <italic>Am</italic></article-title><source>J. Hum. Genet.</source><year>2013</year><volume>92</volume><fpage>667</fpage><lpage>680</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2013.03.022</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giambartolomei</surname><given-names>C</given-names></name><etal/></person-group><article-title>Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics</article-title><source>PLoS Genet</source><year>2014</year><volume>10</volume><fpage>e1004383</fpage><pub-id pub-id-type="doi">10.1371/journal.pgen.1004383</pub-id><?supplied-pmid 24830394?><pub-id pub-id-type="pmid">24830394</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gamazon</surname><given-names>ER</given-names></name><etal/></person-group><article-title>A gene-based association method for mapping traits using reference transcriptome data</article-title><source>Nat. Genet.</source><year>2015</year><volume>47</volume><fpage>1091</fpage><lpage>1098</lpage><pub-id pub-id-type="doi">10.1038/ng.3367</pub-id><?supplied-pmid 26258848?><pub-id pub-id-type="pmid">26258848</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbeira</surname><given-names>AN</given-names></name><etal/></person-group><article-title>Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics</article-title><source>Nat. Commun.</source><year>2018</year><volume>9</volume><fpage>1825</fpage><pub-id pub-id-type="doi">10.1038/s41467-018-03621-1</pub-id><?supplied-pmid 29739930?><pub-id pub-id-type="pmid">29739930</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>J</given-names></name><etal/></person-group><article-title>An integrative genomics approach to the reconstruction of gene networks in segregating populations</article-title><source>Cytogenet. Genome Res.</source><year>2004</year><volume>105</volume><fpage>363</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1159/000078209</pub-id><?supplied-pmid 15237224?><pub-id pub-id-type="pmid">15237224</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schadt</surname><given-names>E</given-names></name><etal/></person-group><article-title>Mapping the Genetic Architecture of Gene Expression in Human Liver</article-title><source>PLoS Biol</source><year>2008</year><volume>6</volume><fpage>e107</fpage><pub-id pub-id-type="doi">10.1371/journal.pbio.0060107</pub-id><?supplied-pmid 18462017?><pub-id pub-id-type="pmid">18462017</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Integrating large-scale functional genomic data to dissect the complexity of yeast regulatory networks</article-title><source>Nat. Genet.</source><year>2008</year><volume>40</volume><fpage>854</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1038/ng.167</pub-id><?supplied-pmid 18552845?><pub-id pub-id-type="pmid">18552845</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="other">Greenawalt, D. M. <italic>et al</italic>. A survey of the genetics of stomach, liver, and adipose gene expression from a morbidly obese cohort. <italic>Genome Res</italic>. <bold>21</bold>, (2011).</mixed-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B</given-names></name><etal/></person-group><article-title>Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer&#x02019;s disease</article-title><source>Cell</source><year>2013</year><volume>153</volume><fpage>707</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.03.030</pub-id><?supplied-pmid 23622250?><pub-id pub-id-type="pmid">23622250</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franz&#x000e9;n</surname><given-names>O</given-names></name><etal/></person-group><article-title>Cardiometabolic risk loci share downstream cis- and trans-gene regulation across tissues and diseases</article-title><source>Science</source><year>2016</year><volume>353</volume><fpage>827</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1126/science.aad6970</pub-id><?supplied-pmid 27540175?><pub-id pub-id-type="pmid">27540175</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>LA</given-names></name><etal/></person-group><article-title>A functional genomics predictive network model identifies regulators of inflammatory bowel disease</article-title><source>Nat. Genet.</source><year>2017</year><volume>49</volume><fpage>1437</fpage><lpage>1449</lpage><pub-id pub-id-type="doi">10.1038/ng.3947</pub-id><?supplied-pmid 28892060?><pub-id pub-id-type="pmid">28892060</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Battle</surname><given-names>A</given-names></name><etal/></person-group><article-title>Characterizing the genetic basis of transcriptome diversity through RNA-sequencing of 922 individuals</article-title><source>Genome Res</source><year>2014</year><volume>24</volume><fpage>14</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1101/gr.155192.113</pub-id><?supplied-pmid 24092820?><pub-id pub-id-type="pmid">24092820</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westra</surname><given-names>H-J</given-names></name><etal/></person-group><article-title>Systematic identification of trans eQTLs as putative drivers of known disease associations</article-title><source>Nat. Genet.</source><year>2013</year><volume>45</volume><fpage>1238</fpage><lpage>1243</lpage><pub-id pub-id-type="doi">10.1038/ng.2756</pub-id><?supplied-pmid 24013639?><pub-id pub-id-type="pmid">24013639</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="other">V&#x000f5;sa, U. <italic>et al</italic>. Unraveling the polygenic architecture of complex traits using blood eQTL meta-analysis. <italic>bioRxiv</italic> Preprint at, <ext-link ext-link-type="uri" xlink:href="http://biorxiv.org/content/early/2018/10/19/447367.abstract">http://biorxiv.org/content/early/2018/10/19/447367.abstract</ext-link> (2018).</mixed-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>T</given-names></name><etal/></person-group><article-title>Identifying gene targets for brain-related traits using transcriptomic and methylomic data from blood</article-title><source>Nat. Commun.</source><year>2018</year><volume>9</volume><fpage>2282</fpage><pub-id pub-id-type="doi">10.1038/s41467-018-04558-1</pub-id><?supplied-pmid 29891976?><pub-id pub-id-type="pmid">29891976</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguet</surname><given-names>F</given-names></name><etal/></person-group><article-title>Genetic effects on gene expression across human tissues</article-title><source>Nature</source><year>2017</year><volume>550</volume><fpage>204</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1038/nature24277</pub-id><pub-id pub-id-type="pmid">29022597</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ardlie</surname><given-names>KG</given-names></name><etal/></person-group><article-title>The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans</article-title><source>Science (80-.)</source><year>2015</year><volume>348</volume><fpage>648</fpage><lpage>660</lpage><pub-id pub-id-type="doi">10.1126/science.1262110</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="data"><year>2015</year><data-title>CommonMind Consortium Data Release Portal</data-title><source>Synapse</source><pub-id pub-id-type="doi">10.7303/syn2759792</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fromer</surname><given-names>M</given-names></name><etal/></person-group><article-title>Gene expression elucidates functional impact of polygenic risk for schizophrenia</article-title><source>Nature Neuroscience</source><year>2016</year><volume>19</volume><fpage>1442</fpage><lpage>1453</lpage><pub-id pub-id-type="doi">10.1038/nn.4399</pub-id><?supplied-pmid 27668389?><pub-id pub-id-type="pmid">27668389</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D</given-names></name><etal/></person-group><article-title>Comprehensive functional genomic resource and integrative model for the human brain</article-title><source>Science (80-.).</source><year>2018</year><volume>362</volume><fpage>eaat8464</fpage><pub-id pub-id-type="doi">10.1126/science.aat8464</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffman</surname><given-names>GE</given-names></name><etal/></person-group><article-title>CommonMind Consortium provides transcriptomic and epigenomic data for Schizophrenia and Bipolar Disorder</article-title><source>Sci. Data</source><year>2019</year><volume>6</volume><fpage>180</fpage><pub-id pub-id-type="doi">10.1038/s41597-019-0183-6</pub-id><?supplied-pmid 31551426?><pub-id pub-id-type="pmid">31551426</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chibnik</surname><given-names>LB</given-names></name><etal/></person-group><article-title>Susceptibility to neurofibrillary tangles: role of the PTPRD locus and limited pleiotropy with other neuropathologies</article-title><source>Mol. Psychiatry</source><year>2017</year><volume>23</volume><fpage>1521</fpage><pub-id pub-id-type="doi">10.1038/mp.2017.20</pub-id><?supplied-pmid 28322283?><pub-id pub-id-type="pmid">28322283</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mostafavi</surname><given-names>S</given-names></name><etal/></person-group><article-title>A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer&#x02019;s disease</article-title><source>Nat. Neurosci.</source><year>2018</year><volume>21</volume><fpage>811</fpage><lpage>819</lpage><pub-id pub-id-type="doi">10.1038/s41593-018-0154-9</pub-id><?supplied-pmid 29802388?><pub-id pub-id-type="pmid">29802388</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>M</given-names></name><etal/></person-group><article-title>Human whole genome genotype and transcriptome data for Alzheimer&#x02019;s and other neurodegenerative diseases</article-title><source>Sci. Data</source><year>2016</year><volume>3</volume><fpage>160089</fpage><pub-id pub-id-type="doi">10.1038/sdata.2016.89</pub-id><?supplied-pmid 27727239?><pub-id pub-id-type="pmid">27727239</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="other">Wan, Y.W. <italic>et al</italic>. Meta-Analysis of the Alzheimer&#x02019;s Disease Human Brain Transcriptome and Functional Dissection in Mouse Models.&#x000a0;<italic>Cell Rep</italic>. <bold>32</bold>(2), 107908 (2020).</mixed-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="data"><year>2015</year><data-title>AMP AD Target Discovery Data Portal</data-title><source>Synapse</source><pub-id pub-id-type="doi">10.7303/syn2580853</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>M</given-names></name><etal/></person-group><article-title>Novel late-onset Alzheimer disease loci variants associate with brain gene expression</article-title><source>Neurology</source><year>2012</year><volume>79</volume><fpage>221</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1212/WNL.0b013e3182605801</pub-id><?supplied-pmid 22722634?><pub-id pub-id-type="pmid">22722634</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname><given-names>F</given-names></name><etal/></person-group><article-title>Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants</article-title><source>PLoS Genet</source><year>2012</year><volume>8</volume><fpage>e1002707</fpage><pub-id pub-id-type="doi">10.1371/journal.pgen.1002707</pub-id><?supplied-pmid 22685416?><pub-id pub-id-type="pmid">22685416</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>M</given-names></name><etal/></person-group><article-title>Late-onset Alzheimer disease risk variants mark brain regulatory loci</article-title><source>Neurol. Genet.</source><year>2015</year><volume>1</volume><fpage>e15</fpage><pub-id pub-id-type="doi">10.1212/NXG.0000000000000012</pub-id><?supplied-pmid 27066552?><pub-id pub-id-type="pmid">27066552</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>B</given-names></name><etal/></person-group><article-title>An xQTL map integrates the genetic architecture of the human brain&#x02019;s transcriptome and epigenome</article-title><source>Nat. Neurosci.</source><year>2017</year><volume>20</volume><fpage>1418</fpage><lpage>1426</lpage><pub-id pub-id-type="doi">10.1038/nn.4632</pub-id><?supplied-pmid 28869584?><pub-id pub-id-type="pmid">28869584</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ripke</surname><given-names>S</given-names></name><etal/></person-group><article-title>Biological insights from 108 schizophrenia-associated genetic loci</article-title><source>Nature</source><year>2014</year><volume>511</volume><fpage>421</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1038/nature13595</pub-id><pub-id pub-id-type="pmid">25056061</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="data"><year>2016</year><data-title>ROSMAP Study</data-title><source>Synapse</source><pub-id pub-id-type="doi">10.7303/syn3219045</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>M</given-names></name><etal/></person-group><article-title>Conserved brain myelination networks are altered in Alzheimer&#x02019;s and other neurodegenerative diseases</article-title><source>Alzheimers. Dement.</source><year>2018</year><volume>14</volume><fpage>352</fpage><lpage>366</lpage><pub-id pub-id-type="doi">10.1016/j.jalz.2017.09.012</pub-id><?supplied-pmid 29107053?><pub-id pub-id-type="pmid">29107053</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>M</given-names></name><etal/></person-group><article-title>Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy</article-title><source>Acta Neuropathol</source><year>2018</year><volume>136</volume><fpage>709</fpage><lpage>727</lpage><pub-id pub-id-type="doi">10.1007/s00401-018-1900-5</pub-id><?supplied-pmid 30136084?><pub-id pub-id-type="pmid">30136084</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="data"><year>2016</year><data-title>Mayo RNAseq Study</data-title><source>Synapse</source><pub-id pub-id-type="doi">10.7303/syn5550404</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leek</surname><given-names>JT</given-names></name><name><surname>Storey</surname><given-names>JD</given-names></name></person-group><article-title>Capturing Heterogeneity in Gene Expression Studies by Surrogate Variable Analysis</article-title><source>Plos Genet</source><year>2007</year><volume>3</volume><fpage>e161</fpage><pub-id pub-id-type="doi">10.1371/journal.pgen.0030161</pub-id><?supplied-pmid 1994707?><pub-id pub-id-type="pmid">1994707</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarthy</surname><given-names>S</given-names></name><etal/></person-group><article-title>A reference panel of 64,976 haplotypes for genotype imputation</article-title><source>Nat. Genet.</source><year>2016</year><volume>48</volume><fpage>1279</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1038/ng.3643</pub-id><?supplied-pmid 27548312?><pub-id pub-id-type="pmid">27548312</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Brien</surname><given-names>HE</given-names></name><etal/></person-group><article-title>Expression quantitative trait loci in the developing human brain and their enrichment in neuropsychiatric disorders</article-title><source>Genome Biol</source><year>2018</year><volume>19</volume><fpage>194</fpage><pub-id pub-id-type="doi">10.1186/s13059-018-1567-1</pub-id><?supplied-pmid 30419947?><pub-id pub-id-type="pmid">30419947</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Schizophrenia-associated rs4702 G allele-specific downregulation of FURIN expression by miR-338-3p reduces BDNF production</article-title><source>Schizophr. Res.</source><year>2018</year><volume>199</volume><fpage>176</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1016/j.schres.2018.02.040</pub-id><?supplied-pmid 29499969?><pub-id pub-id-type="pmid">29499969</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobbyn</surname><given-names>A</given-names></name><etal/></person-group><article-title>Landscape of Conditional eQTL in Dorsolateral Prefrontal Cortex and Co-localization with Schizophrenia GWAS. <italic>Am</italic></article-title><source>J. Hum. Genet.</source><year>2018</year><volume>102</volume><fpage>1169</fpage><lpage>1184</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2018.04.011</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pardi&#x000f1;as</surname><given-names>AF</given-names></name><etal/></person-group><article-title>Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection</article-title><source>Nat. Genet.</source><year>2018</year><volume>50</volume><fpage>381</fpage><lpage>389</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0059-2</pub-id><?supplied-pmid 29483656?><pub-id pub-id-type="pmid">29483656</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Non-coding RNA dysregulation in the amygdala region of schizophrenia patients contributes to the pathogenesis of the disease</article-title><source>Transl. Psychiatry</source><year>2018</year><volume>8</volume><fpage>44</fpage><pub-id pub-id-type="doi">10.1038/s41398-017-0030-5</pub-id><?supplied-pmid 29391398?><pub-id pub-id-type="pmid">29391398</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>AT</given-names></name><etal/></person-group><article-title>Genetic architecture of epigenetic and neuronal ageing rates in human brain regions</article-title><source>Nat. Commun.</source><year>2017</year><volume>8</volume><fpage>15353</fpage><pub-id pub-id-type="doi">10.1038/ncomms15353</pub-id><?supplied-pmid 28516910?><pub-id pub-id-type="pmid">28516910</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>MN</given-names></name><etal/></person-group><article-title>Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood</article-title><source>Genome Biol</source><year>2012</year><volume>13</volume><fpage>R43</fpage><pub-id pub-id-type="doi">10.1186/gb-2012-13-6-r43</pub-id><?supplied-pmid 22703893?><pub-id pub-id-type="pmid">22703893</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hannon</surname><given-names>E</given-names></name><name><surname>Lunnon</surname><given-names>K</given-names></name><name><surname>Schalkwyk</surname><given-names>L</given-names></name><name><surname>Mill</surname><given-names>J</given-names></name></person-group><article-title>Interindividual methylomic variation across blood, cortex, and cerebellum: implications for epigenetic studies of neurological and neuropsychiatric phenotypes</article-title><source>Epigenetics</source><year>2015</year><volume>10</volume><fpage>1024</fpage><lpage>1032</lpage><pub-id pub-id-type="doi">10.1080/15592294.2015.1100786</pub-id><?supplied-pmid 26457534?><pub-id pub-id-type="pmid">26457534</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guintivano</surname><given-names>J</given-names></name><name><surname>Aryee</surname><given-names>MJ</given-names></name><name><surname>Kaminsky</surname><given-names>ZA</given-names></name></person-group><article-title>A cell epigenotype specific model for the correction of brain cellular heterogeneity bias and its application to age, brain region and major depression</article-title><source>Epigenetics</source><year>2013</year><volume>8</volume><fpage>290</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.4161/epi.23924</pub-id><?supplied-pmid 23426267?><pub-id pub-id-type="pmid">23426267</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Negi</surname><given-names>SK</given-names></name><name><surname>Guda</surname><given-names>C</given-names></name></person-group><article-title>Global gene expression profiling of healthy human brain and its application in studying neurological disorders</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><fpage>897</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-00952-9</pub-id><?supplied-pmid 28420888?><pub-id pub-id-type="pmid">28420888</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azevedo</surname><given-names>FAC</given-names></name><etal/></person-group><article-title>Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain</article-title><source>J. Comp. Neurol.</source><year>2009</year><volume>513</volume><fpage>532</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1002/cne.21974</pub-id><?supplied-pmid 19226510?><pub-id pub-id-type="pmid">19226510</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>S</given-names></name><name><surname>Hsieh</surname><given-names>Y-P</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>C</given-names></name></person-group><article-title>Low-input and multiplexed microfluidic assay reveals epigenomic variation across cerebellum and prefrontal cortex</article-title><source>Sci. Adv.</source><year>2018</year><volume>4</volume><fpage>eaar8187</fpage><pub-id pub-id-type="doi">10.1126/sciadv.aar8187</pub-id><?supplied-pmid 29675472?><pub-id pub-id-type="pmid">29675472</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westra</surname><given-names>H-J</given-names></name><etal/></person-group><article-title>Cell Specific eQTL Analysis without Sorting Cells</article-title><source>Plos Genet</source><year>2015</year><volume>11</volume><fpage>e1005223</fpage><pub-id pub-id-type="doi">10.1371/journal.pgen.1005223</pub-id><?supplied-pmid 25955312?><pub-id pub-id-type="pmid">25955312</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Wijst</surname><given-names>MGP</given-names></name><etal/></person-group><article-title>Single-cell RNA sequencing identifies celltype-specific cis-eQTLs and co-expression QTLs</article-title><source>Nat. Genet.</source><year>2018</year><volume>50</volume><fpage>493</fpage><lpage>497</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0089-9</pub-id><?supplied-pmid 29610479?><pub-id pub-id-type="pmid">29610479</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><mixed-citation publication-type="other">Wang, J., Devlin, B. &#x00026; Roeder, K. Using multiple measurements of tissue to estimate individual- and cell-type-specific gene expression via deconvolution. <italic>bioRxiv</italic> 379099, 10.1101/379099 (2018).</mixed-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M</given-names></name><etal/></person-group><article-title>Integrative functional genomic analysis of human brain development and neuropsychiatric risks</article-title><source>Science (80-.).</source><year>2018</year><volume>362</volume><fpage>eaat7615</fpage><pub-id pub-id-type="doi">10.1126/science.aat7615</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname><given-names>A</given-names></name><etal/></person-group><article-title>STAR: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><year>2013</year><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name></person-group><article-title>featureCounts: an efficient general purpose program for assigning sequence reads to genomic features</article-title><source>Bioinformatics</source><year>2014</year><volume>30</volume><fpage>923</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btt656</pub-id><?supplied-pmid 24227677?><pub-id pub-id-type="pmid">24227677</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname><given-names>KD</given-names></name><name><surname>Irizarry</surname><given-names>RA</given-names></name><name><surname>WU</surname><given-names>Z</given-names></name></person-group><article-title>Removing technical variability in RNA-seq data using conditional quantile normalization</article-title><source>Biostatistics</source><year>2012</year><volume>13</volume><fpage>204</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1093/biostatistics/kxr054</pub-id><?supplied-pmid 22285995?><pub-id pub-id-type="pmid">22285995</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritchie</surname><given-names>ME</given-names></name><etal/></person-group><article-title>limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title><source>Nucleic Acids Res</source><year>2015</year><volume>43</volume><fpage>e47</fpage><lpage>e47</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv007</pub-id><?supplied-pmid 25605792?><pub-id pub-id-type="pmid">25605792</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Law</surname><given-names>CW</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><article-title>Voom: precision weights unlock linear model analysis tools for RNA-seq read counts</article-title><source>Genome Biol.</source><year>2014</year><volume>15</volume><fpage>R29</fpage><pub-id pub-id-type="doi">10.1186/gb-2014-15-2-r29</pub-id><?supplied-pmid 24485249?><pub-id pub-id-type="pmid">24485249</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pearson</surname><given-names>K</given-names></name></person-group><article-title>LIII. On lines and planes of closest fit to systems of points in space</article-title><source>London, Edinburgh, Dublin Philos. Mag. J. Sci</source><year>1901</year><volume>2</volume><fpage>559</fpage><lpage>572</lpage><pub-id pub-id-type="doi">10.1080/14786440109462720</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hotelling</surname><given-names>H</given-names></name></person-group><article-title>Analysis of a complex of statistical variables into principal components</article-title><source>J. Educ. Psychol.</source><year>1933</year><volume>24</volume><fpage>417</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.1037/h0071325</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><mixed-citation publication-type="other">Leek, J. T. <italic>et al</italic>. Bioconductor - sva., 10.18129/B9.bioc.sva (2018).</mixed-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>H</given-names></name><name><surname>Braak</surname><given-names>E</given-names></name></person-group><article-title>Neuropathological stageing of Alzheimer-related changes</article-title><source>Acta Neuropathol.</source><year>1991</year><volume>82</volume><fpage>239</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1007/BF00308809</pub-id><?supplied-pmid 1759558?><pub-id pub-id-type="pmid">1759558</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandler</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>A total score for the CERAD neuropsychological battery</article-title><source>Neurology</source><year>2005</year><volume>65</volume><fpage>102</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1212/01.wnl.0000167607.63000.38</pub-id><?supplied-pmid 16009893?><pub-id pub-id-type="pmid">16009893</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>CC</given-names></name><etal/></person-group><article-title>Second-generation PLINK: rising to the challenge of larger and richer datasets</article-title><source>Gigascience</source><year>2015</year><volume>4</volume><fpage>7</fpage><pub-id pub-id-type="doi">10.1186/s13742-015-0047-8</pub-id><?supplied-pmid 25722852?><pub-id pub-id-type="pmid">25722852</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>S</given-names></name><etal/></person-group><article-title>Next-generation genotype imputation service and methods</article-title><source>Nat. Genet.</source><year>2016</year><volume>48</volume><fpage>1284</fpage><lpage>1287</lpage><pub-id pub-id-type="doi">10.1038/ng.3656</pub-id><?supplied-pmid 27571263?><pub-id pub-id-type="pmid">27571263</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loh</surname><given-names>P-R</given-names></name><etal/></person-group><article-title>Reference-based phasing using the Haplotype Reference Consortium panel</article-title><source>Nat. Genet.</source><year>2016</year><volume>48</volume><fpage>1443</fpage><pub-id pub-id-type="doi">10.1038/ng.3679</pub-id><?supplied-pmid 27694958?><pub-id pub-id-type="pmid">27694958</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><mixed-citation publication-type="other">Klei, L., Kent, B. P., Melhem, N., Devlin, B. &#x00026; Roeder, K. GemTools: A fast and efficient approach to estimating genetic ancestry. (2011).</mixed-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>AB</given-names></name><name><surname>Luca</surname><given-names>D</given-names></name><name><surname>Klei</surname><given-names>L</given-names></name><name><surname>Devlin</surname><given-names>B</given-names></name><name><surname>Roeder</surname><given-names>K</given-names></name></person-group><article-title>Discovering genetic ancestry using spectral graph theory</article-title><source>Genet. Epidemiol.</source><year>2010</year><volume>34</volume><fpage>51</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1002/gepi.20541</pub-id><?supplied-pmid 19455578?><pub-id pub-id-type="pmid">19455578</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shabalin</surname><given-names>AA</given-names></name></person-group><article-title>Matrix eQTL: ultra fast eQTL analysis via large matrix operations</article-title><source>Bioinformatics</source><year>2012</year><volume>28</volume><fpage>1353</fpage><lpage>1358</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts163</pub-id><?supplied-pmid 22492648?><pub-id pub-id-type="pmid">22492648</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Begum</surname><given-names>F</given-names></name><name><surname>Ghosh</surname><given-names>D</given-names></name><name><surname>Tseng</surname><given-names>GC</given-names></name><name><surname>Feingold</surname><given-names>E</given-names></name></person-group><article-title>Comprehensive literature review and statistical considerations for GWAS meta-analysis</article-title><source>Nucleic Acids Res</source><year>2012</year><volume>40</volume><fpage>3777</fpage><lpage>3784</lpage><pub-id pub-id-type="doi">10.1093/nar/gkr1255</pub-id><?supplied-pmid 22241776?><pub-id pub-id-type="pmid">22241776</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="data"><name><surname>O&#x02019;Brien</surname><given-names>H</given-names></name><name><surname>Bray</surname><given-names>NJ</given-names></name><year>2018</year><data-title>Summary statistics for expression quantitative trait loci in the developing human brain and their enrichment in neuropsychiatric disorders</data-title><source>Figshare</source><pub-id pub-id-type="doi">10.6084/m9.figshare.6881825.v1</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><mixed-citation publication-type="other">Storey, J.D., Bass, A.J., Dabney, A. &#x00026; Robinson, D.&#x000a0;<italic>qvalue: Q-value estimation for false discovery rate control</italic><ext-link ext-link-type="uri" xlink:href="http://github.com/jdstorey/qvalue">http://github.com/jdstorey/qvalue</ext-link> (2020).</mixed-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="data"><name><surname>Sieberts</surname><given-names>S</given-names></name><year>2019</year><data-title>ROSMAP DLPFC eQTL</data-title><source>Synapse</source><pub-id pub-id-type="doi">10.7303/syn16984409.1</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="data"><name><surname>Sieberts</surname><given-names>S</given-names></name><year>2019</year><data-title>Mayo Temporal Cortex eQTL</data-title><source>Synapse</source><pub-id pub-id-type="doi">10.7303/syn16984410.1</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="data"><name><surname>Sieberts</surname><given-names>S</given-names></name><year>2019</year><data-title>Mayo Cerebellum eQTL</data-title><source>Synapse</source><pub-id pub-id-type="doi">10.7303/syn16984411.1</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="data"><name><surname>Sieberts</surname><given-names>S</given-names></name><year>2019</year><data-title>Cortical eQTL Meta-analysis</data-title><source>Synapse</source><pub-id pub-id-type="doi">10.7303/syn16984815.1</pub-id></element-citation></ref></ref-list></back></article>